Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
51000,,,5304007,[],CHEMBL1695966,Antimicrobial activity against rifampicin-sensitive Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337281,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.25
51001,,,5304008,[],CHEMBL1696462,"Ratio of Cmax in healthy human at 400 mg/kg, po administered as a single dose to MIC90 for Mycobacterium tuberculosis",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337281,=,1,0,=,,Ratio,,,8.6,CHEMBL612545,,Unchecked,,,,Ratio,,,,8.6
51002,,,5304009,[],CHEMBL1696463,Antimicrobial activity against Mycobacterium tuberculosis infected in patients with tuberculosis assessed as percentage of patients with negative culture after 4 weeks,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1337281,=,1,0,=,,Activity,%,,37.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,%,UO_0000187,,37.0
51003,,,5305434,[],CHEMBL1696168,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in absence of thymidine,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
51004,,,5305446,[],CHEMBL1696169,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in presence of thymidine,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
51005,,,5306486,[],CHEMBL1696170,Antibacterial activity against revertant Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
51006,,,5306498,[],CHEMBL1696171,Antibacterial activity against normal phenotype Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51007,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5306510,[],CHEMBL1696172,Cmax in human plasma,A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1337313,=,1,1,=,,Cmax,nM,,9964.13,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cmax,ug ml-1,UO_0000065,,4.0
51008,,,5306522,[],CHEMBL1696173,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,=,1,1,=,,Fu,,,0.5,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Fu,%,,,50.0
51009,,,5306526,[],CHEMBL1696174,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU after 5 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,=,1,0,=,,log10cfu,,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,1.0
51010,,,5306528,[],CHEMBL1696176,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,=,1,0,=,,log10cfu,,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,1.0
51011,,,5306536,[],CHEMBL1696166,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,=,1,0,=,,log10cfu,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,3.0
51012,,Active,5306552,[],CHEMBL1696181,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level after 24 hrs in presence of thymidine,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
51013,,,5306570,[],CHEMBL1696177,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein at up to 10'5 times MIC after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,=,1,0,=,,log10cfu,,,-1.32,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,-1.32
51014,,,5306582,[],CHEMBL1696178,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,=,1,0,=,,log10cfu,,,2.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,2.49
51015,,,5306594,[],CHEMBL1696179,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level at up to 10'5 times MIC after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,<,1,0,<,,log10CFU/ml,,,-4.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,-4.5
51016,,,5306606,[],CHEMBL1696180,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337313,=,1,0,=,,log10CFU/ml,,,3.01,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.01
51017,,,5306618,[],CHEMBL1696305,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth at pH 5.5 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51018,,,5306630,[],CHEMBL1696306,Antibacterial activity against normal phenotype Staphylococcus aureus in cation-adjusted MH 2 broth at pH 5.5 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51019,,,5307455,[],CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
51020,,,5307456,[],CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
51021,,,5307457,[],CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
51022,,,5307458,[],CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
51023,,,5307459,[],CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
51024,,,5307460,[],CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51025,,,5307461,[],CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51026,,,5307462,[],CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
51027,,,5307463,[],CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
51028,,,5307464,[],CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51029,,,5307465,[],CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51030,,,5307466,[],CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
51031,,,5307467,[],CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
51032,,,5307468,[],CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51033,,,5307469,[],CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
51034,,,5307470,[],CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51035,,,5307471,[],CHEMBL1694346,Antibacterial activity against Escherichia coli ATCC 25922 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,2.0
51036,,,5307472,[],CHEMBL1694347,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
51037,,,5307473,[],CHEMBL1694348,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
51038,,,5307474,[],CHEMBL1694527,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
51039,,,5307475,[],CHEMBL1694528,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
51040,,,5307476,[],CHEMBL1694624,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,16.0
51041,,,5307477,[],CHEMBL1694625,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,Activity,ug ml-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,32.0
51042,,,5307478,[],CHEMBL1694626,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,Activity,ug ml-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,32.0
51043,,,5307479,[],CHEMBL1694627,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1338562,=,1,0,=,,Ratio,,,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,250.0
51044,,,5307480,[],CHEMBL1694628,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1338562,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
51045,,,5307481,[],CHEMBL1694629,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1338562,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
51046,,,5307482,[],CHEMBL1694630,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1338562,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
51047,,,5307483,[],CHEMBL1694631,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 harboring GyrA S83L mutant,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1338562,=,1,0,=,,Ratio,,,66.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,66.7
51048,,,5307484,[],CHEMBL1694632,Ratio of mutant prevention concentration to MIC for qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1338562,=,1,0,=,,Ratio,,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,64.0
51049,,,5307485,[],CHEMBL1694633,Ratio of mutant prevention concentration to MIC for qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1338562,=,1,0,=,,Ratio,,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,64.0
51050,,,5307486,[],CHEMBL1694634,Ratio of mutant prevention concentration to MIC for qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1338562,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
51051,,,5307487,[],CHEMBL1694635,Antibacterial activity against Escherichia coli ATCC 25922 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
51052,,,5307488,[],CHEMBL1694636,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
51053,,,5307489,[],CHEMBL1694637,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
51054,,,5307490,[],CHEMBL1694638,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
51055,,,5307491,[],CHEMBL1694639,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
51056,,,5307492,[],CHEMBL1694640,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
51057,,,5307493,[],CHEMBL1694641,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
51058,,,5307494,[],CHEMBL1694642,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
51059,,,5307495,[],CHEMBL1694643,Antibacterial activity against Escherichia coli ATCC 25922 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
51060,,,5307496,[],CHEMBL1694644,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51061,,,5307497,[],CHEMBL1694646,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51062,,,5307498,[],CHEMBL1694647,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51063,,,5307499,[],CHEMBL1694648,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
51064,,,5307500,[],CHEMBL1694649,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51065,,,5307501,[],CHEMBL1694650,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
51066,,,5307502,[],CHEMBL1694651,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
51067,,,5307503,[],CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.015
51068,,,5307504,[],CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
51069,,,5307505,[],CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
51070,,,5307506,[],CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
51071,,,5307507,[],CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.125
51072,,,5307508,[],CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
51073,,,5307509,[],CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
51074,,,5307510,[],CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
51075,,,5307511,[],CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.008
51076,,,5307512,[],CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
51077,,,5307513,[],CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
51078,,,5307514,[],CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
51079,,,5307515,[],CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
51080,,,5307516,[],CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
51081,,,5307517,[],CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
51082,,,5307518,[],CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
51083,,,5312392,[],CHEMBL1695549,Antimicrobial activity against toxin and capsule gene-deficient Bacillus anthracis Sterne after 24 hrs by macrobroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337737,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,mg/L,UO_0000274,,0.06
51084,,,5312393,[],CHEMBL1695551,Antimicrobial activity against toxin and capsule gene-deficient Bacillus anthracis Sterne after 24 hrs by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,MBC,mg/L,,1.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MBC,mg/L,,,1.0
51085,,,5312394,[],CHEMBL1695550,Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,91.2,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,91.2
51086,,,5312395,[],CHEMBL1695552,Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,188.0,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,188.0
51087,,,5312396,[],CHEMBL1695553,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,13.0,CHEMBL612558,,ADMET,,,,CL,L/hr,,,13.0
51088,,,5312397,[],CHEMBL1695554,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,12.0,CHEMBL612558,,ADMET,,,,CL,L/hr,,,12.0
51089,,,5312398,[],CHEMBL1695555,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.24,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.24
51090,,,5312399,[],CHEMBL1695556,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.4,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.4
51091,,,5312400,[],CHEMBL1695652,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.338,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.338
51092,,,5312401,[],CHEMBL1695653,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.151,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.151
51093,,,5312402,[],CHEMBL1695654,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.24,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.24
51094,,,5312403,[],CHEMBL1695655,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,6.41,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,6.41
51095,,,5312404,[],CHEMBL1695656,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.86,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.86
51096,,,5312405,[],CHEMBL1695657,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,19.8,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,19.8
51097,,,5312406,[],CHEMBL1695658,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.46,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.46
51098,,,5312407,[],CHEMBL1695659,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.667,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.667
51099,,,5312408,[],CHEMBL1695660,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.08,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.08
51100,,,5312409,[],CHEMBL1695661,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.91,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.91
51101,,,5312410,[],CHEMBL1695662,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,29.8,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,29.8
51102,,,5312411,[],CHEMBL1695663,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,5.93,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,5.93
51103,,,5312412,[],CHEMBL1695976,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.63,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.63
51104,,,5312413,[],CHEMBL1695977,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,7.38,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,7.38
51105,,,5312414,[],CHEMBL1695978,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,4.96,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,4.96
51106,,,5312415,[],CHEMBL1695979,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.2,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.2
51107,,,5312416,[],CHEMBL1695980,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,7.31,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,7.31
51108,,,5312417,[],CHEMBL1695981,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.41,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.41
51109,,,5312418,[],CHEMBL1695982,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,41200000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,41200000.0
51110,,,5312419,[],CHEMBL1695983,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,38500000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,38500000.0
51111,,,5312420,[],CHEMBL1695984,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,169.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,169.0
51112,,,5312421,[],CHEMBL1695985,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,99.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,99.0
51113,,,5312422,[],CHEMBL1695986,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1740000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1740000.0
51114,,,5312423,[],CHEMBL1695987,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1880000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1880000.0
51115,,,5312424,[],CHEMBL1695988,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,32.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,32.0
51116,,,5312425,[],CHEMBL1695989,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,25.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,25.0
51117,,,5312426,[],CHEMBL1695990,Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,97.9,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,97.9
51118,,,5312427,[],CHEMBL1695991,Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,75.0,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,75.0
51119,,,5312428,[],CHEMBL1695992,Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,95.3,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,95.3
51120,,,5312429,[],CHEMBL1695993,Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,91.4,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,91.4
51121,,,5312430,[],CHEMBL1695994,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,12.4,CHEMBL612558,,ADMET,,,,CL,L/hr,,,12.4
51122,,,5312431,[],CHEMBL1696108,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,14.2,CHEMBL612558,,ADMET,,,,CL,L/hr,,,14.2
51123,,,5312432,[],CHEMBL1696109,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,13.0,CHEMBL612558,,ADMET,,,,CL,L/hr,,,13.0
51124,,,5312433,[],CHEMBL1696110,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,13.3,CHEMBL612558,,ADMET,,,,CL,L/hr,,,13.3
51125,,,5312434,[],CHEMBL1696111,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.26,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.26
51126,,,5312435,[],CHEMBL1696112,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.25,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.25
51127,,,5312436,[],CHEMBL1696113,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.25,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.25
51128,,,5312437,[],CHEMBL1696114,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.25,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.25
51129,,,5312438,[],CHEMBL1696115,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.276,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.276
51130,,,5312439,[],CHEMBL1696116,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.12,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.12
51131,,,5312440,[],CHEMBL1696117,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.353,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.353
51132,,,5312441,[],CHEMBL1696118,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.339,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.339
51133,,,5312442,[],CHEMBL1696119,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.28,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.28
51134,,,5312443,[],CHEMBL1696120,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.28,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.28
51135,,,5312444,[],CHEMBL1696121,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.28,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.28
51136,,,5312445,[],CHEMBL1696122,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.28,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.28
51137,,,5312446,[],CHEMBL1696123,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,17.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,17.9
51138,,,5312447,[],CHEMBL1696124,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,25.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,25.0
51139,,,5312448,[],CHEMBL1696125,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,16.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,16.9
51140,,,5312449,[],CHEMBL1696126,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,8.07,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,8.07
51141,,,5312450,[],CHEMBL1696127,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.246,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.246
51142,,,5312451,[],CHEMBL1696128,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.315,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.315
51143,,,5312452,[],CHEMBL1696129,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.462,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.462
51144,,,5312453,[],CHEMBL1696130,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.548,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.548
51145,,,5312454,[],CHEMBL1696131,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.63,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.63
51146,,,5312455,[],CHEMBL1696132,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.37,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.37
51147,,,5312456,[],CHEMBL1696133,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.11,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.11
51148,,,5312457,[],CHEMBL1696134,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.08,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.08
51149,,,5312458,[],CHEMBL1695581,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,20.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,20.9
51150,,,5312459,[],CHEMBL1696663,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,30.0
51151,,,5312460,[],CHEMBL1696664,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,30.0
51152,,,5312461,[],CHEMBL1696665,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,30.0
51153,,,5312462,[],CHEMBL1696666,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.74,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.74
51154,,,5312463,[],CHEMBL1696667,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.74,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.74
51155,,,5312464,[],CHEMBL1696792,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.73,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.73
51156,,,5312465,[],CHEMBL1696793,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.73,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.73
51157,,,5312466,[],CHEMBL1696794,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.17,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.17
51158,,,5312467,[],CHEMBL1696795,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,4.94,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,4.94
51159,,,5312468,[],CHEMBL1696796,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,5.3,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,5.3
51160,,,5312469,[],CHEMBL1696797,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,5.18,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,5.18
51161,,,5312470,[],CHEMBL1696798,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,10.1,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,10.1
51162,,,5312471,[],CHEMBL1696799,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,9.06,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,9.06
51163,,,5312472,[],CHEMBL1696800,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,6.65,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,6.65
51164,,,5312473,[],CHEMBL1696801,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,7.23,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,7.23
51165,,,5312474,[],CHEMBL1696802,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,20600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,20600000.0
51166,,,5312475,[],CHEMBL1696803,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,23500000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,23500000.0
51167,,,5312476,[],CHEMBL1696804,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,20600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,20600000.0
51168,,,5312477,[],CHEMBL1696805,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,21600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,21600000.0
51169,,,5312478,[],CHEMBL1696806,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,50.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,50.0
51170,,,5312479,[],CHEMBL1696807,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,169.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,169.0
51171,,,5312480,[],CHEMBL1696808,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,222.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,222.0
51172,,,5312481,[],CHEMBL1696809,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,80.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,80.0
51173,,,5312482,[],CHEMBL1696810,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1860000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1860000.0
51174,,,5312483,[],CHEMBL1696811,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1880000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1880000.0
51175,,,5312484,[],CHEMBL1696812,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1870000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1870000.0
51176,,,5312485,[],CHEMBL1696813,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1860000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1860000.0
51177,,,5312486,[],CHEMBL1696814,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,15.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,15.0
51178,,,5312487,[],CHEMBL1696815,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,32.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,32.0
51179,,,5312488,[],CHEMBL1696816,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,34.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,34.0
51180,,,5312489,[],CHEMBL1696817,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,22.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,22.0
51181,,,5312490,[],CHEMBL1696818,"Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,188.0,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,188.0
51182,,,5312491,[],CHEMBL1696819,"Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,201.0,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,201.0
51183,,,5312492,[],CHEMBL1696820,"Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,186.0,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,186.0
51184,,,5312493,[],CHEMBL1696821,"Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,190.0,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,190.0
51185,,,5312494,[],CHEMBL1696926,"Virtual volume of the central compartment in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Liter,1337737,=,1,0,=,,Vc,l,,188.0,CHEMBL612558,,ADMET,,,,Vc,l,UO_0000099,,188.0
51186,,,5312495,[],CHEMBL1696927,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,12.1,CHEMBL612558,,ADMET,,,,CL,L/hr,,,12.1
51187,,,5312496,[],CHEMBL1696928,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,10.8,CHEMBL612558,,ADMET,,,,CL,L/hr,,,10.8
51188,,,5312497,[],CHEMBL1696929,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,11.1,CHEMBL612558,,ADMET,,,,CL,L/hr,,,11.1
51189,,,5312498,[],CHEMBL1696930,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,12.7,CHEMBL612558,,ADMET,,,,CL,L/hr,,,12.7
51190,,,5312499,[],CHEMBL1696931,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CL,L/hr,,11.9,CHEMBL612558,,ADMET,,,,CL,L/hr,,,11.9
51191,,,5312500,[],CHEMBL1696932,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,5.14,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,5.14
51192,,,5312501,[],CHEMBL1696933,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,6.57,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,6.57
51193,,,5313520,[],CHEMBL1696934,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,7.42,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,7.42
51194,,,5313521,[],CHEMBL1696935,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.81,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.81
51195,,,5313522,[],CHEMBL1696936,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.31,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.31
51196,,,5313523,[],CHEMBL1696937,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.478,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.478
51197,,,5313524,[],CHEMBL1696308,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.82,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.82
51198,,,5313525,[],CHEMBL1697447,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.0407,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.0407
51199,,,5313526,[],CHEMBL1697448,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.152,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.152
51200,,,5313527,[],CHEMBL1697449,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.161,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.161
51201,,,5313528,[],CHEMBL1697450,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,6.24,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,6.24
51202,,,5313529,[],CHEMBL1697451,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,7.48,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,7.48
51203,,,5313530,[],CHEMBL1697452,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,6.58,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,6.58
51204,,,5313531,[],CHEMBL1697453,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,4.29,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,4.29
51205,,,5313532,[],CHEMBL1697454,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,4.48,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,4.48
51206,,,5313533,[],CHEMBL1697455,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,20.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,20.0
51207,,,5313534,[],CHEMBL1697456,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,13.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,13.9
51208,,,5313535,[],CHEMBL1697457,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,19.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,19.9
51209,,,5313536,[],CHEMBL1697458,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,20.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,20.0
51210,,,5313537,[],CHEMBL1697459,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,16.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,16.9
51211,,,5313538,[],CHEMBL1697460,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.393,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.393
51212,,,5313539,[],CHEMBL1697461,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.516,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.516
51213,,,5313540,[],CHEMBL1697462,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.227,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.227
51214,,,5313541,[],CHEMBL1697463,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.719,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.719
51215,,,5313542,[],CHEMBL1697464,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.667,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.667
51216,,,5313543,[],CHEMBL1697465,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.984,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.984
51217,,,5313544,[],CHEMBL1697466,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.707,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.707
51218,,,5313545,[],CHEMBL1697581,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.16,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.16
51219,,,5313546,[],CHEMBL1697582,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.89,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.89
51220,,,5313547,[],CHEMBL1697583,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.27,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.27
51221,,,5313548,[],CHEMBL1697584,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,5.84,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,5.84
51222,,,5313549,[],CHEMBL1697585,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,30.0
51223,,,5313550,[],CHEMBL1697586,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,30.0
51224,,,5313551,[],CHEMBL1697587,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.0
51225,,,5313552,[],CHEMBL1697588,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.0
51226,,,5313553,[],CHEMBL1697589,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,6.77,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,6.77
51227,,,5313554,[],CHEMBL1697590,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,16.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,16.0
51228,,,5313555,[],CHEMBL1697591,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,7.6,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,7.6
51229,,,5313556,[],CHEMBL1697592,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,6.91,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,6.91
51230,,,5313557,[],CHEMBL1697593,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,7.29,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,7.29
51231,,,5313558,[],CHEMBL1697594,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.0657,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.0657
51232,,,5313559,[],CHEMBL1697595,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.38,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.38
51233,,,5313560,[],CHEMBL1697596,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,0.0657,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,0.0657
51234,,,5313561,[],CHEMBL1697597,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.09,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.09
51235,,,5313562,[],CHEMBL1697598,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.91,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.91
51236,,,5313563,[],CHEMBL1697599,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.91,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.91
51237,,,5313564,[],CHEMBL1697600,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,25.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,25.9
51238,,,5313565,[],CHEMBL1697601,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,2.27,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,2.27
51239,,,5313566,[],CHEMBL1697602,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.01,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.01
51240,,,5313567,[],CHEMBL1697603,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,Activity,/hr,,1.04,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,/hr,,,1.04
51241,,,5313568,[],CHEMBL1697604,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,19600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,19600000.0
51242,,,5313569,[],CHEMBL1697605,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,28000000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,28000000.0
51243,,,5313570,[],CHEMBL1697606,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,21500000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,21500000.0
51244,,,5313571,[],CHEMBL1697607,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,53600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,53600000.0
51245,,,5313572,[],CHEMBL1697608,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,36000000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,36000000.0
51246,,,5313573,[],CHEMBL1696990,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,677.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,677.0
51247,,,5313574,[],CHEMBL1695582,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,71.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,71.0
51248,,,5313575,[],CHEMBL1695583,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,629.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,629.0
51249,,,5313576,[],CHEMBL1695584,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,96.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,96.0
51250,,,5313577,[],CHEMBL1695585,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,45.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,45.0
51251,,,5313578,[],CHEMBL1695586,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1860000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1860000.0
51252,,,5313579,[],CHEMBL1695587,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1900000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1900000.0
51253,,,5313580,[],CHEMBL1695588,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,1890000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,1890000.0
51254,,,5313581,[],CHEMBL1695589,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,2420000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,2420000.0
51255,,,5313582,[],CHEMBL1695590,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,2360000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,2360000.0
51256,,,5313583,[],CHEMBL1695591,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,41.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,41.0
51257,,,5313584,[],CHEMBL1695592,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,21.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,21.0
51258,,,5313585,[],CHEMBL1695692,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,40.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,40.0
51259,,,5313586,[],CHEMBL1695693,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,24.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,24.0
51260,,,5313587,[],CHEMBL1695694,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1337737,=,1,0,=,,CFU/ml,,,15.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,CFU/ml,,,,15.0
51261,,drug-induced liver injury reported,5317609,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1341395,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
51262,,no drug-induced liver injury reported,5318560,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1341395,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
51263,,no drug-induced liver injury reported,5319511,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1341395,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
51264,,,6159997,[],CHEMBL1764237,Antitubercular activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1759873,Bioorg Med Chem Lett,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1412571,=,1,1,=,,MIC,nM,,290.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.29
51265,,,6160042,[],CHEMBL1764238,Antitubercular activity against Mycobacterium tuberculosis H37Rv by LORA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1759873,Bioorg Med Chem Lett,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1412571,=,1,1,=,,MIC,nM,,31100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,31.1
51266,,,6172602,[],CHEMBL1767999,Antimicrobial activity against Bacillus cereus ATCC 11778 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.3
51267,,,6172611,[],CHEMBL1768000,Antimicrobial activity against Bacillus megaterium ATCC 19213 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,0.003
51268,,,6172620,[],CHEMBL1768001,Antimicrobial activity against Bacillus subtilis ATCC 6633 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.015
51269,,,6172629,[],CHEMBL1768002,Antimicrobial activity against Bacillus thuringiensis var.kurstaki BGSC 4D1 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
51270,,,6172638,[],CHEMBL1768003,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
51271,,,6172647,[],CHEMBL1768004,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 72 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.0
51272,,,6172656,[],CHEMBL1768005,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 4790 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
51273,,,6172665,[],CHEMBL1768006,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.07
51274,,,6172674,[],CHEMBL1768007,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus epidermidis clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,50.0
51275,,,6172683,[],CHEMBL1768008,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.15
51276,,,6172692,[],CHEMBL1768009,Antimicrobial activity against quinilone-pencillin-resistant Acinetobacter baumannii clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,50.0
51277,,,6172701,[],CHEMBL1768010,Antimicrobial activity against Escherichia coli ATCC 8739 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
51278,,,6172710,[],CHEMBL1768011,Antimicrobial activity against quinilone-pencillin-resistant Escherichia coli clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
51279,,,6172719,[],CHEMBL1768012,Antimicrobial activity against Haemophilus influenzae ATCC 19418 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
51280,,,6172728,[],CHEMBL1768013,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.7
51281,,,6172737,[],CHEMBL1768014,Antimicrobial activity against Saccharomyces cerevisiae ATCC 9763 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,100.0
51282,,,6172747,[],CHEMBL1768015,Antimicrobial activity against Candida tropicalis ATCC 1369 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,,MIC,ug ml-1,UO_0000274,,100.0
51283,,,6173383,[],CHEMBL1768201,Antimicrobial activity against Aspergillus niger ATCC 6275 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,MIC,ug ml-1,UO_0000274,,100.0
51284,,,6173389,[],CHEMBL1768202,Inhibition of Escherichia coli DNA gyrase assessed as reduction of DNA supercoiling activity using pBR322 DNA substrate after 30 mins by electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,IC50,ug.mL-1,,0.85,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.85
51285,,,6173393,[],CHEMBL1768203,Inhibition of Escherichia coli topoisomerase 4 assessed as decatenation of kDNA after 30 mins by electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,,IC50,ug.mL-1,,5.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,5.0
51286,,,6184721,[],CHEMBL1775353,Antibacterial activity against Escherichia coli ATCC25922 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421986,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
51287,,,6184798,[],CHEMBL1775350,Inhibition of wild-type Staphylococcus aureus topoisomerase 4-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.0,0,http://www.openphacts.org/units/Nanomolar,1421986,=,1,1,=,,IC50,nM,,1000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,1.0
51288,,,6184805,[],CHEMBL1775351,Inhibition of wild-type Staphylococcus aureus DNA gyrase assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1772978,J Med Chem,2011.0,"{'bei': '12.74', 'le': '0.24', 'lle': '2.74', 'sei': '6.10'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.11,0,http://www.openphacts.org/units/Nanomolar,1421986,=,1,1,=,,IC50,nM,,7700.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,7.7
51289,,,6184812,[],CHEMBL1775357,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421986,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51290,,,6184819,[],CHEMBL1775519,Inhibition of Staphylococcus aureus topoisomerase 4 Ser80Phe mutant-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.92,0,http://www.openphacts.org/units/Nanomolar,1421986,=,1,1,=,,IC50,nM,,11900.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,11.9
51291,,,6184826,[],CHEMBL1775520,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,P20831,S84L,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1772978,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1421986,>,1,1,>,,IC50,nM,,200000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,IC50,uM,UO_0000065,,200.0
51292,,,6199607,[],CHEMBL1775349,Cytotoxicity against human Hep2 cells after 72 hrs by alamar blue assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1421986,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,100.0
51293,,,6199659,[],CHEMBL1775348,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421986,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
51294,,,6199677,[],CHEMBL1775352,Antibacterial activity against methicillin- and quinolone-resistant Staphylococcus aureus ATCC700699 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421986,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51295,,,6212923,[],CHEMBL1787728,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781930,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1427239,=,1,1,=,,MIC,nM,,470.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.47
51296,,,6228614,[],CHEMBL1785786,Cytotoxicity against MDCK cells after 48 hrs by CPE assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1427623,=,1,1,=,,CC50,nM,,161000.0,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,,CC50,uM,UO_0000065,,161.0
51297,,,6229772,[],CHEMBL1785609,Antibacterial activity against 10'4 CFU Staphylococcus aureus ATCC 25923 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
51298,,,6229773,[],CHEMBL1785610,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
51299,,,6229774,[],CHEMBL1785772,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51300,,,6229775,[],CHEMBL1785773,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
51301,,,6229776,[],CHEMBL1785774,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus epidermidis 09-2 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
51302,,,6229777,[],CHEMBL1785775,Antibacterial activity against 10'4 CFU Streptococcus pneumoniae 08-4 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
51303,,,6229778,[],CHEMBL1785776,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-10 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
51304,,,6229779,[],CHEMBL1785777,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-12 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
51305,,,6229780,[],CHEMBL1785778,Antibacterial activity against 10'4 CFU Enterococcus faecium 08-2 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
51306,,,6229781,[],CHEMBL1785779,Antibacterial activity against 10'4 CFU Enterococcus faecium 06-7 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
51307,,,6229782,[],CHEMBL1785780,Antibacterial activity against 10'4 CFU Escherichia coli ATCC 25922 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51308,,,6229783,[],CHEMBL1785781,Antibacterial activity against 10'4 CFU Escherichia coli 08-21 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51309,,,6229784,[],CHEMBL1785782,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-22 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
51310,,,6229785,[],CHEMBL1785783,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-23 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
51311,,,6229786,[],CHEMBL1785784,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
51312,,,6229787,[],CHEMBL1785785,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa 09-32 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
51313,,,6258468,[],CHEMBL1798233,Antitubercular activity against replicating Mycobacterium tuberculosis H37Rv ATCC 27294 after 1 week by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1795314,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437546,=,1,1,=,,MIC,ug.mL-1,,0.83,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.83
51314,,,6258479,[],CHEMBL1798148,Antitubercular activity against non-replicating Mycobacterium tuberculosis H37Rv ATCC 27294 incubated 10 days under anaerobic condition measured after 28 hrs of recovery in air by luciferase based low oxygen recovery assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1795314,Eur J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437546,=,1,1,=,,MIC,ug.mL-1,,33.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,33.2
51315,,,6300743,[],CHEMBL1811600,Antibacterial activity against Escherichia coli KD65,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443962,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.156
51316,,,6300755,[],CHEMBL1811601,Antibacterial activity against tolC knockout Escherichia coli KD1397,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443962,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
51317,,,6300767,[],CHEMBL1811602,Antibacterial activity against Mycobacterium smegmatis KD1163,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443962,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.08
51318,,,7836022,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_bilirubinemia,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,1.0
51319,,,7836023,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
51320,,,7836024,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
51321,,,7836025,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
51322,,,7836026,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
51323,,,7836027,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_hepatic failure,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,1.0
51324,,,7836028,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_hepatic necrosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,0.0
51325,,,7836029,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_hepatitis,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,1.0
51326,,,7836030,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_hepatomegaly,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,0.0
51327,,,7836031,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_jaundice,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,1.0
51328,,,7836032,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
51329,,,7836033,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
51330,,,7836034,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_liver function tests abnormal,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,1.0
51331,,,7836035,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1541347,=,1,0,=,,HepSE_Combined Scores,,,5.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,5.0
51332,,,7849142,[],CHEMBL1914224,Antimicrobial activity against replicating Mycobacterium tuberculosis after 8 days by micro plate alamar blue assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909569,Bioorg Med Chem Lett,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1543706,=,1,1,=,,MIC90,nM,,640.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.64
51333,,,7849175,[],CHEMBL1914225,Antimicrobial activity against non-replicating Mycobacterium tuberculosis after 11 days by luminescence based low oxygen recovery assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909569,Bioorg Med Chem Lett,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1543706,=,1,1,=,,MIC90,nM,,4300.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,4.3
51334,,,7975772,[],CHEMBL1929933,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51335,,,7975773,[],CHEMBL1929934,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51336,,,7975774,[],CHEMBL1929935,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51337,,,7975775,[],CHEMBL1929936,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51338,,,7975776,[],CHEMBL1929937,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51339,,,7975777,[],CHEMBL1929938,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51340,,,7975778,[],CHEMBL1931190,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51341,,,7975779,[],CHEMBL1931191,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51342,,,7975780,[],CHEMBL1931192,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51343,,,7975781,[],CHEMBL1931193,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-5 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
51344,,,7975782,[],CHEMBL1931194,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-6 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51345,,,7975783,[],CHEMBL1931195,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
51346,,,7975784,[],CHEMBL1931196,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
51347,,,7975785,[],CHEMBL1931197,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
51348,,,7975786,[],CHEMBL1931198,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
51349,,,7975787,[],CHEMBL1931199,Antibacterial activity against Streptococcus pneumoniae 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
51350,,,7975788,[],CHEMBL1931200,Antibacterial activity against Enterococcus faecium 09-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
51351,,,7975789,[],CHEMBL1931201,Antibacterial activity against Enterococcus faecium 09-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
51352,,,7975790,[],CHEMBL1931202,Antibacterial activity against Enterococcus faecium 09-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.008
51353,,,7975791,[],CHEMBL1931203,Antibacterial activity against Enterococcus faecium 09-5 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
51354,,,7975792,[],CHEMBL1931204,Antibacterial activity against Enterococcus faecium 09-6 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.125
51355,,,7975793,[],CHEMBL1931205,Antibacterial activity against Enterococcus faecalis 09-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
51356,,,7975794,[],CHEMBL1931206,Antibacterial activity against Enterococcus faecalis 09-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
51357,,,7975795,[],CHEMBL1931207,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
51358,,,7975796,[],CHEMBL1931208,Antibacterial activity against Escherichia coli 09-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
51359,,,7975797,[],CHEMBL1931209,Antibacterial activity against Escherichia coli 09-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
51360,,,7975798,[],CHEMBL1931287,Antibacterial activity against Escherichia coli 09-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
51361,,,7975799,[],CHEMBL1929633,Antibacterial activity against Escherichia coli 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
51362,,,7975800,[],CHEMBL1929634,Antibacterial activity against Escherichia coli 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51363,,,7975801,[],CHEMBL1929635,Antibacterial activity against Escherichia coli 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
51364,,,7975802,[],CHEMBL1929636,Antibacterial activity against Klebsiella pneumoniae 09-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
51365,,,7975803,[],CHEMBL1929637,Antibacterial activity against Klebsiella pneumoniae 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
51366,,,7975804,[],CHEMBL1929638,Antibacterial activity against Klebsiella pneumoniae 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
51367,,,7975805,[],CHEMBL1929639,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51368,,,7975806,[],CHEMBL1929640,Antibacterial activity against Pseudomonas aeruginosa 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
51369,,,7975807,[],CHEMBL1929641,Antibacterial activity against Pseudomonas aeruginosa 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51370,,,7975808,[],CHEMBL1929642,Antibacterial activity against Pseudomonas aeruginosa 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
51371,,,7977060,[],CHEMBL1929863,Antibacterial activity against Enterococcus faecium 09-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
51372,,,8017193,[],CHEMBL1948997,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1944533,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1576017,=,1,1,=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
51373,,,10935888,[],CHEMBL2051639,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as minimum concentration required to inhibit 90% growth after 1 week by fluorescence-based microplate Alamar Blue assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2046299,Bioorg Med Chem Lett,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1653724,=,1,1,=,,MIC90,ug.mL-1,,0.39,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.39
51374,,,10935933,[],CHEMBL2051640,Antitubercular activity against non-replicating Mycobacterium tuberculosis assessed as minimum concentration required to inhibit 90% growth after 10 days under anaerobic condition by luciferase-based low-oxygen recovery assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2046299,Bioorg Med Chem Lett,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1653724,=,1,1,=,,MIC90,ug.mL-1,,15.93,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,15.93
51375,,Not Determined,10935941,[],CHEMBL2051641,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTS assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2046299,Bioorg Med Chem Lett,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1653724,,1,0,,,IC50,,,,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,,,,
51376,,,10936328,[],CHEMBL2049320,Antitubercular activity against Mycobacterium tuberculosis H37Rv in aerobic conditions after 7 days by microplate-based alamar blue assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2046330,J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1651821,=,1,1,=,,MIC90,nM,,460.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.46
51377,,,10953145,[],CHEMBL2061991,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2057135,Bioorg Med Chem Lett,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658094,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
51378,,,10953177,[],CHEMBL2061992,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2057135,Bioorg Med Chem Lett,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658094,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
51379,,,10979118,[],CHEMBL2066579,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658369,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.25
51380,,,10979119,[],CHEMBL2066579,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658369,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,8.0
51381,,,12070066,[],CHEMBL2162879,Inhibition of human ERG expressed in mammalian cells by patch clamp method,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1732872,>,1,1,>,,IC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,uM,UO_0000065,,30.0
51382,,,12070073,[],CHEMBL2162878,Inhibition of human ERG expressed in mammalian cells at 10 uM by patch clamp method,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1732872,=,1,1,=,,Inhibition,%,,10.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,INH,%,UO_0000187,,10.0
51383,,Not Determined,12070084,[],CHEMBL2162877,Cytotoxicity against human HepG2 cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1732872,,1,0,,,CC50,,,,CHEMBL395,Homo sapiens,HepG2,9606.0,,,CC50,,,,
51384,,Not Determined,12070095,[],CHEMBL2162876,Cytotoxicity against human HeLa cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1732872,,1,0,,,CC50,,,,CHEMBL399,Homo sapiens,HeLa,9606.0,,,CC50,,,,
51385,,Not Determined,12070106,[],CHEMBL2162875,Cytotoxicity against human CHO cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1732872,,1,0,,,CC50,,,,CHEMBL613853,Cricetulus griseus,CHO,10029.0,,,CC50,,,,
51386,,,12070117,[],CHEMBL2162874,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 5-FQR4M BSA678 expressing GyrA Ser84Leu and Ser85Pro mutant and GrlA Ser80Phe and Glu84Lys mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
51387,,,12070128,[],CHEMBL2162873,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 4-FQR3M BSA643 expressing GyrA Ser84Leu mutant and GrlA Ser80Tyr and Glu84Gly mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
51388,,,12070139,[],CHEMBL2162872,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 3-FQR3M ATCC 700699 expressing GyrA Ser84Leu mutant and Glu409Lys mutant and GrlA Ser80Phe mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51389,,,12070150,[],CHEMBL2162871,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 2-FQR2M NY2746 expressing GyrA Ser84Leu mutant and GrlA Ser80Phe mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51390,,,12070161,[],CHEMBL2162870,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 1-FQR2M BK2384 expressing GyrA Ser84Leu mutant and GrlA Ser80Phe mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51391,,,12070172,[],CHEMBL2161981,Cytotoxicity against human Hep2 cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1732872,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,100.0
51392,,,12070193,[],CHEMBL2161980,Inhibition of Staphylococcus aureus topoisomerase 4 by decatenation assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.0,0,http://www.openphacts.org/units/Nanomolar,1732872,=,1,1,=,,IC50,nM,,1000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,1.0
51393,,,12070214,[],CHEMBL2161979,Inhibition of Staphylococcus aureus DNA gyrase by supercoiling assay,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,"{'bei': '11.82', 'le': '0.22', 'lle': '2.37', 'sei': '5.66'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.75,0,http://www.openphacts.org/units/Nanomolar,1732872,=,1,1,=,,IC50,nM,,18000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,18.0
51394,,,12070235,[],CHEMBL2161978,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51395,,,12070256,[],CHEMBL2161977,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
51396,,,12086998,[],CHEMBL2169381,"Antimycobacterial activity against Mycobacterium tuberculosis infected in human assessed as log reduction of bacterial count at 400 mg, qd measured up to 2 days",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2163329,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1736139,=,1,0,=,,log10CFU/ml/day,,,0.33,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10CFU/ml/day,,,,0.33
51397,,,12087000,[],CHEMBL2169382,"AUC in human at 400 mg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2163329,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1736139,=,1,1,=,,AUC,ng.hr.mL-1,,39000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,microg.hr/mL,,,39.0
51398,,,12087002,[],CHEMBL2169384,"Half life in human at 400 mg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2163329,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1736139,=,1,1,=,,T1/2,hr,,9.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,9.1
51399,,,12087004,[],CHEMBL2169383,"Tmax in human at 400 mg, po",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2163329,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1736139,=,1,1,=,,Tmax,hr,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.0
51400,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,12087007,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL2169386,"Cmax in human at 400 mg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2163329,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1736139,=,1,1,=,,Cmax,nM,,10711.44,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,4.3
51401,,,12087009,[],CHEMBL2169385,Bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2163329,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1736139,=,1,1,=,,F,%,,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,90.0
51402,,,12087012,[],CHEMBL2169387,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2163329,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1736139,=,1,1,=,,MIC90,ug.mL-1,,0.031,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.031
51403,,,12087016,[],CHEMBL2169388,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2163329,Eur J Med Chem,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1736139,=,1,1,=,,MIC,ug.mL-1,,0.18,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.18
51404,,,12398094,[],CHEMBL3061303,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by MABA,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3045173,Med Chem Res,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,1797769,=,1,1,=,,MIC90,nM,,250.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.25
51405,,,12398106,[],CHEMBL3061303,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by MABA,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3045173,Med Chem Res,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1797769,=,1,1,=,,Inhibition,%,,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,INH,%,UO_0000187,,100.0
51406,,,12532080,[],CHEMBL3077731,"Drug uptake in Mus musculus (mouse) serum at 100 mg/kg, po at 0.25 hr",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3046014,Med Chem Res,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825956,=,1,0,=,,Drug uptake,ug ml-1,,7.8,CHEMBL613590,Mus musculus,Serum,10090.0,,,Drug uptake,ug ml-1,UO_0000274,,7.8
51407,,,12532081,[],CHEMBL3077733,Antitubercular activity against Mycobacterium tuberculosis CSU93,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3046014,Med Chem Res,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825956,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
51408,,,12532082,[],CHEMBL3077734,Elimination half life in healthy Homo sapiens (human),A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3046014,Med Chem Res,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,1825956,=,1,1,=,,T1/2,hr,,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,beta t1/2,hr,UO_0000032,,12.0
51409,,,12644208,[],CHEMBL2330392,Plasma protein binding in human at 5 ug/mL by ultrafiltration method,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1853496,=,1,1,=,,PPB,%,,47.8,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,47.8
51410,,,12644209,[],CHEMBL2330394,Aqueous solubility of the compound,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,Solubility,ug.mL-1,,777.0,CHEMBL2362975,,No relevant target,,,,solubility,ug ml-1,UO_0000274,,777.0
51411,,,12644210,[],CHEMBL2330393,"Chloroform-phosphate buffer apparent partition coefficient of the compound, log P at pH 7.4",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1853496,=,1,1,=,,LogP,,,53.8,CHEMBL2362975,,No relevant target,,,,logP,,,,53.8
51412,,,12644211,[],CHEMBL2330395,Inhibition of human ERG expressed in CHOK1 cells at 100 uM,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1853496,=,1,1,=,,Inhibition,%,,42.3,CHEMBL240,Homo sapiens,HERG,9606.0,,,INH,%,UO_0000187,,42.3
51413,,,12644212,[],CHEMBL2330396,Inhibition of human ERG expressed in CHOK1 cells at 30 uM,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1853496,=,1,1,=,,Inhibition,%,,21.5,CHEMBL240,Homo sapiens,HERG,9606.0,,,INH,%,UO_0000187,,21.5
51414,,,12644213,[],CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
51415,,,12644214,[],CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC80,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC80,ug ml-1,UO_0000274,,4.0
51416,,,12644215,[],CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,2.0
51417,,,12644216,[],CHEMBL2330399,Antibacterial activity against Chlamydophila pneumoniae CM-1 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,,MIC,ug ml-1,UO_0000274,,0.125
51418,,,12644217,[],CHEMBL2330400,Antibacterial activity against Chlamydophila pneumoniae AR39 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,,MIC,ug ml-1,UO_0000274,,0.125
51419,,,12644218,[],CHEMBL2330401,Antibacterial activity against Mycoplasma pneumoniae ATCC 29085 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.12
51420,,,12644219,[],CHEMBL2330402,Antibacterial activity against Mycoplasma pneumoniae 18-1 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.25
51421,,,12644220,[],CHEMBL2330440,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
51422,,,12644221,[],CHEMBL2330441,Antibacterial activity against Moraxella catarrhalis ATCC 25238 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.05
51423,,,12644222,[],CHEMBL2330442,Antibacterial activity against Haemophilus influenzae ATCC 49247 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.012
51424,,,12644223,[],CHEMBL2330444,Antibacterial activity against Klebsiella pneumoniae TYPE1 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
51425,,,12644224,[],CHEMBL2330443,Antibacterial activity against Escherichia coli NIHJ after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
51426,,,12644225,[],CHEMBL2330445,Antibacterial activity against Bacillus subtilis IID 685 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.2
51427,,,12644226,[],CHEMBL2330447,Antibacterial activity against Enterococcus faecalis ATCC 19433 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.2
51428,,,12644227,[],CHEMBL2330446,Antibacterial activity against Streptococcus pyogenes G-36 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.2
51429,,,12644228,[],CHEMBL2330448,"Antibacterial activity against quinolone, penicillin-resistant Streptococcus pneumoniae 104835 after 18 hrs by microbroth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,3.13
51430,,,12644229,[],CHEMBL2330449,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae J24 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.1
51431,,,12644230,[],CHEMBL2330450,Antibacterial activity against Staphylococcus epidermidis 56500 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.1
51432,,,12644231,[],CHEMBL2330451,Antibacterial activity against levofloxacin-resistant and methicillin-resistant Staphylococcus aureus 870307 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
51433,,,12644232,[],CHEMBL2330452,Antibacterial activity against Staphylococcus aureus FDA 209-P after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
51434,,Not Active,12712812,[],CHEMBL2344499,Inhibition of Mycobacterium leprae wild type DNA gyrase GyrA/GyrB G89C mutant-mediated DNA cleavable complex formation assessed as compound concentration inducing 25% DNA cleavage using relaxed pBR322 DNA substrate incubated for 1 hr at 30 degC by agarose gel electrophoresis,B,Q57532,G89C,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2331356,Bioorg Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1873914,,1,0,,,CC25,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,,,,
51435,,,12712863,[],CHEMBL2344500,Inhibition of Mycobacterium leprae wild type DNA gyrase GyrA/GyrB A91V mutant-mediated DNA cleavable complex formation assessed as compound concentration inducing 25% DNA cleavage using relaxed pBR322 DNA substrate incubated for 1 hr at 30 degC by agarose gel electrophoresis,B,Q57532,A91V,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2331356,Bioorg Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1873914,=,1,0,=,,CC25,ug ml-1,,12.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,12.0
51436,,,12712875,[],CHEMBL2344501,Inhibition of Mycobacterium leprae wild type DNA gyrase GyrA/GyrB-mediated DNA cleavable complex formation assessed as compound concentration inducing 25% DNA cleavage using relaxed pBR322 DNA substrate incubated for 1 hr at 30 degC by agarose gel electrophoresis,B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2331356,Bioorg Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1873914,=,1,0,=,,CC25,ug ml-1,,2.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,2.0
51437,,,12712877,[],CHEMBL2344502,Inhibition of Mycobacterium leprae DNA gyrase GyrA/GyrB assessed as reduction of enzyme supercoiling activity using relaxed pBR322 DNA substrate incubated for 2 hrs at 30 degC by ethidium bromide based gel electrophoresis,B,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2331356,Bioorg Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1873914,=,1,1,=,,IC50,ug.mL-1,,2.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,2.0
51438,,,12712878,[],CHEMBL2344503,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrA/GyrB assessed as reduction of enzyme supercoiling activity using relaxed pBR322 DNA substrate incubated for 1 hr at 37 degC by ethidium bromide based gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2331356,Bioorg Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1873914,=,1,1,=,,IC50,ug.mL-1,,2.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,ug ml-1,UO_0000274,,2.0
51439,,,12712882,[],CHEMBL2344504,Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed as drug concentration causing =<1% reduction in bacterial growth incubated for 21 to 30 days by proportion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2331356,Bioorg Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1873914,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
51440,,,13356449,[],CHEMBL2400450,Inhibition of human ERG current by patch clamp assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2396647,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://www.openphacts.org/units/Nanomolar,1901918,=,1,1,=,,IC50,nM,,129000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,uM,UO_0000065,,129.0
51441,,,13373771,[],CHEMBL2406615,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51442,,,13373796,[],CHEMBL2406616,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51443,,,13373830,[],CHEMBL2406617,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51444,,,13373858,[],CHEMBL2406618,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51445,,,13373866,[],CHEMBL2406619,Antibacterial activity against Escherichia coli CCARM 1356 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
51446,,,13373911,[],CHEMBL2406620,Antibacterial activity against Staphylococcus aureus KCTC 503 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51447,,,13373933,[],CHEMBL2406621,Antibacterial activity against Staphylococcus aureus KCTC 209 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51448,,,13375348,[],CHEMBL2406622,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51449,,,13404379,[],CHEMBL2415954,fT>MIC in Mycobacterium tuberculosis infected mouse,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1911950,=,1,0,=,,fT>MIC,%,,80.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,80.0
51450,,,13404380,[],CHEMBL2415953,T>MIC in Mycobacterium tuberculosis infected mouse,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1911950,=,1,0,=,,%T>MIC,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,%T>MIC,%,UO_0000187,,100.0
51451,,,13404381,[],CHEMBL2415956,fAUC/MIC in Mycobacterium tuberculosis infected mouse,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1911950,=,1,0,=,,fAUC/MIC,,,53.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fAUC/MIC,,,,53.0
51452,,,13404382,[],CHEMBL2415955,AUC/MIC in Mycobacterium tuberculosis infected mouse,F,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1911950,=,1,0,=,,RatioAUC/MIC,,,88.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,RatioAUC/MIC,,,,88.0
51453,,,13404383,[],CHEMBL2415958,fCmax/MIC in Mycobacterium tuberculosis infected mouse,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1911950,=,1,0,=,,fCmax/MIC,,,10.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fCmax/MIC,,,,10.0
51454,,,13404384,[],CHEMBL2415957,Cmax/MIC in Mycobacterium tuberculosis infected mouse,F,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1911950,=,1,0,=,,Ratio,,,17.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,17.0
51455,,Acidic pKa,13518150,[],CHEMBL2449011,pKa (acid-base dissociation constant) as determined by potentiometric titration,P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2448811,Pharm Res,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1932424,,1,0,,,pKa,,,6.3,CHEMBL2362975,,No relevant target,,,,pKa,,,,6.3
51456,,Basic pKa,13518151,[],CHEMBL2449011,pKa (acid-base dissociation constant) as determined by potentiometric titration,P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2448811,Pharm Res,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1932424,,1,0,,,pKa,,,9.3,CHEMBL2362975,,No relevant target,,,,pKa,,,,9.3
51457,,Basic pKa,13518152,[],CHEMBL2449010,pKa (acid-base dissociation constant) as determined by other workers,P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2448811,Pharm Res,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1932424,,1,0,,,pKa,,,9.14,CHEMBL2362975,,No relevant target,,,,pKa,,,,9.14
51458,,Acidic pKa,13518153,[],CHEMBL2449010,pKa (acid-base dissociation constant) as determined by other workers,P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL2448811,Pharm Res,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1932424,,1,0,,,pKa,,,6.2,CHEMBL2362975,,No relevant target,,,,pKa,,,,6.2
51459,,,13518585,[],CHEMBL2449582,"CL/F in plasma of patient with intracerebral and leptomeningeal tuberculosis at 400 mg/kg, po QD measured on day 3",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255350,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,961471,=,1,0,=,,CL/F,,,71.34,CHEMBL612558,,ADMET,,,,CL/F,,,,71.34
51460,,,13518586,[],CHEMBL2449583,"CL/F  in plasma of patient with intracerebral and leptomeningeal tuberculosis at 800 mg/kg, po QD measured on day 3",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255350,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,961471,=,1,0,=,,CL/F,,,32.3,CHEMBL612558,,ADMET,,,,CL/F,,,,32.3
51461,,,13518587,[],CHEMBL2449580,"CL/F in CSF of patient with intracerebral and leptomeningeal tuberculosis at 400 mg/kg, po QD measured on day 3",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255350,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,961471,=,1,0,=,,CL/F,,,81.1,CHEMBL612558,,ADMET,,,,CL/F,,,,81.1
51462,,,13518588,[],CHEMBL2449581,"CL/F in CSF of patient with intracerebral and leptomeningeal tuberculosis at 800 mg/kg, po QD measured on day 3",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255350,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,961471,=,1,0,=,,CL/F,,,46.0,CHEMBL612558,,ADMET,,,,CL/F,,,,46.0
51463,,,13825740,[],CHEMBL3089103,Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA G96V mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3085704,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1949273,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.12
51464,,,13825745,[],CHEMBL3089104,Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA M103L mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3085704,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1949273,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.12
51465,,,13825750,[],CHEMBL3089105,Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA M103I mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3085704,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1949273,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.12
51466,,,13825780,[],CHEMBL3089492,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as parasite growth inhibition after 7 days by Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3085704,J Med Chem,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1949273,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.12
51467,,,13905233,[],CHEMBL3117232,Antimicrobial activity against quinolone-resistant Staphylococcus aureus clinical isolate 3519 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51468,,,13905258,[],CHEMBL3117233,Antimicrobial activity against quinolone-resistant Staphylococcus aureus clinical isolate 3505 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51469,,,13905283,[],CHEMBL3117234,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 3506 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51470,,,13905308,[],CHEMBL3117235,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 3167 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51471,,,13905331,[],CHEMBL3117236,Antimicrobial activity against Candida albicans 7535 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,0.5
51472,,,13905354,[],CHEMBL3117237,Antimicrobial activity against Salmonella typhimurium 1926 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
51473,,,13905377,[],CHEMBL3117238,Antimicrobial activity against Salmonella typhimurium 2421 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
51474,,,13905400,[],CHEMBL3117239,Antimicrobial activity against Pseudomonas aeruginosa 2004 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
51475,,,13905423,[],CHEMBL3117240,Antimicrobial activity against Pseudomonas aeruginosa 2742 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51476,,,13905446,[],CHEMBL3117241,Antimicrobial activity against Escherichia coli CCARM 1356 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
51477,,,13905469,[],CHEMBL3117242,Antimicrobial activity against Escherichia coli KCTC 1924 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51478,,,13906094,[],CHEMBL3117243,Antimicrobial activity against Streptococcus mutans 3065 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,ug ml-1,UO_0000274,,0.25
51479,,,13906117,[],CHEMBL3117244,Antimicrobial activity against Staphylococcus aureus 503 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51480,,,13906140,[],CHEMBL3117245,Antimicrobial activity against Staphylococcus aureus 209 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51481,,,13906163,[],CHEMBL3117246,Antimicrobial activity against Staphylococcus aureus RN4220 after 20 hrs by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3112479,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51482,,,13948727,[],CHEMBL3131756,"Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6 mouse assessed as reduction of bacterial CFU in lung at 30 mg/kg, po administered for 8 days measured 24 hrs post last dose relative to control",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3124857,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1970563,=,1,0,=,,FC,,,3.48,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,FC,,,,3.48
51483,,Active,13948739,[],CHEMBL3131768,Bactericidal activity against Mycobacterium tuberculosis H37Rv assessed as log reduction of bacterial CFU at 1.2 ug/mL after 1 week,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3124857,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1970563,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
51484,,references out of a total of 4,13984864,[],CHEMBL3137722,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (moderate),,,3.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),,,,3.0
51485,,,13984865,[],CHEMBL3137723,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1979836,=,1,0,=,,Hepatotoxicity (moderate),%,,6.9,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),%,UO_0000187,,6.9
51486,,references out of a total of 4,13984866,[],CHEMBL3137724,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (acute),,,2.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (acute),,,,2.0
51487,,,13984867,[],CHEMBL3137725,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,1979836,=,1,0,=,,Hepatotoxicity (acute),%,,0.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (acute),%,UO_0000187,,0.3
51488,,references out of a total of 4,13984868,[],CHEMBL3137726,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (cytolytic),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cytolytic),,,,0.0
51489,,references out of a total of 4,13984869,[],CHEMBL3137727,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (choleostasis),,,1.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (choleostasis),,,,1.0
51490,,references out of a total of 4,13984870,[],CHEMBL3137728,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (severe hepatitis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (severe hepatitis),,,,0.0
51491,,references out of a total of 4,13984871,[],CHEMBL3137729,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (chronic liver disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (chronic liver disease),,,,0.0
51492,,references out of a total of 4,13984872,[],CHEMBL3137730,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (cirrhosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cirrhosis),,,,0.0
51493,,references out of a total of 4,13984873,[],CHEMBL3137731,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (granulomatous hepatitis),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (granulomatous hepatitis),,,,0.0
51494,,references out of a total of 4,13984874,[],CHEMBL3137732,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (association with vascular disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (association with vascular disease),,,,0.0
51495,,references out of a total of 4,13984875,[],CHEMBL3137733,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (steatosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (steatosis),,,,0.0
51496,,references out of a total of 4,13984876,[],CHEMBL3137734,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (malignant tumour),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (malignant tumour),,,,0.0
51497,,references out of a total of 4,13984877,[],CHEMBL3137735,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,=,1,0,=,,Hepatotoxicity (benign tumour),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (benign tumour),,,,0.0
51498,,,13984878,[],CHEMBL3137736,Animal toxicity known. [column 'TOXIC' in source],T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,,1,0,,,Hepatotoxicity (animal toxicity known),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (animal toxicity known),,,,
51499,,,13984879,[],CHEMBL3137737,Presence of at least one case with successful reintroduction. [column 'REINT' in source],T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,,1,0,,,Hepatotoxicity (successful reintroduction),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (successful reintroduction),,,,
51500,,,13984880,[],CHEMBL3137738,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,,1,0,,,Hepatotoxicity (comment),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (comment),,,,
51501,,26 days,13984881,[],CHEMBL3137739,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,,1,0,,,Hepatotoxicity (time to onset),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (time to onset),,,,
51502,,Dose-dependant,13984882,[],CHEMBL3137740,Proposed mechanism(s) of liver damage. [column 'MEC' in source],T,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,1979836,,1,0,,,Hepatotoxicity (mechanism),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (mechanism),,,,
51503,,,14591644,[],CHEMBL3240962,Antibacterial activity against 1 ug/ml Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2087679,=,1,1,=,,MIC,nM,,156.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.156
51504,,,14591645,[],CHEMBL3240963,Antibacterial activity against 0.5 ug/ml Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2087679,=,1,1,=,,MIC,nM,,156.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.156
51505,,,14591646,[],CHEMBL3241107,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 741 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.0625
51506,,,14591647,[],CHEMBL3241108,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 753 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.0625
51507,,,14591648,[],CHEMBL3241109,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 758 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.0625
51508,,,14591649,[],CHEMBL3241110,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 760 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.0625
51509,,,14591650,[],CHEMBL3241111,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 821 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
51510,,,14591651,[],CHEMBL3241112,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 930 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.0
51511,,,14591652,[],CHEMBL3241113,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1237 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
51512,,,14591653,[],CHEMBL3240134,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1256 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,2.0
51513,,,14591654,[],CHEMBL3240135,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1259 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.0
51514,,,14591655,[],CHEMBL3240136,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1288 assessed as growth inhibition after 7 days by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.125
51515,,,14720237,[],CHEMBL3292117,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286390,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,,MIC,nM,,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.125
51516,,,14720248,[],CHEMBL3292118,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 OE mutant assessed as growth inhibition after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286390,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,,MIC,nM,,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.125
51517,,,14720259,[],CHEMBL3292119,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 C387S mutant assessed as growth inhibition after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286390,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,,MIC,nM,,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.125
51518,,,14720270,[],CHEMBL3292120,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 C387G mutant assessed as growth inhibition after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286390,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,,MIC,nM,,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.125
51519,,,14720281,[],CHEMBL3292121,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 Y314H mutant assessed as growth inhibition after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286390,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,,MIC,nM,,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.125
51520,,,14720292,[],CHEMBL3292122,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 Rv1937/F426C mutant assessed as growth inhibition after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286390,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,,MIC,nM,,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.125
51521,,Not Active,14743707,[],CHEMBL3294046,Antimycobacterial activity against spontaneously resistant mutant of Mycobacterium tuberculosis H37Rv at 10 to 20 times MIC up to 6 to 8 weeks,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2118300,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
51522,,,14743732,[],CHEMBL3294029,Antimycobacterial activity against wild-type Mycobacterium tuberculosis H37Rv ATCC 27294 after 16 to 18 days by BACTEC 7H12B microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118300,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.06
51523,,,14743748,[],CHEMBL3294030,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase holoenzyme-mediated supercoiling of pBR322 DNA after 90 mins by agarose gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,"{'bei': '12.21', 'le': '0.23', 'lle': '2.53', 'sei': '5.85'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.9,0,http://www.openphacts.org/units/Nanomolar,2118300,=,1,1,=,,IC50,nM,,12500.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,12.5
51524,,,14744146,[],CHEMBL3296295,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by standard microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286182,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,,MIC,nM,,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.15
51525,,,14744297,[],CHEMBL3296315,Antimycobacterial activity against Mycobacterium tuberculosis over expressing DprE1 after 5 days by standard microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286182,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,,MIC,nM,,80.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.08
51526,,,14744305,[],CHEMBL3296316,Antimycobacterial activity against Mycobacterium tuberculosis over expressing InhA after 5 days by standard microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286182,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,,MIC,nM,,160.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.16
51527,,,14744313,[],CHEMBL3296317,Antimycobacterial activity against Mycobacterium tuberculosis over expressing TopA after 5 days by standard microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286182,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,,MIC,nM,,310.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.31
51528,,,14744321,[],CHEMBL3296318,Antimycobacterial activity against Mycobacterium tuberculosis over expressing PimA after 5 days by standard microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286182,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,,MIC,nM,,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.15
51529,,,14744332,[],CHEMBL3296319,Antimycobacterial activity against BTZ043-resistant Mycobacterium tuberculosis over expressing DprE1 C387S mutant after 5 days by standard microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286182,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,,MIC,nM,,80.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.08
51530,,,14744340,[],CHEMBL3296320,Antimycobacterial activity against TMC207R-resistant Mycobacterium tuberculosis clone 8.1 over expressing DprE1 mutant after 5 days by standard microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286182,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,,MIC,nM,,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.15
51531,,,14744348,[],CHEMBL3296321,Antimycobacterial activity against moxifloxacin-resistant Mycobacterium tuberculosis clone 4.1 over expressing DprE1 mutant after 5 days by standard microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286182,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,,MIC,nM,,10000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,10.0
51532,,Active,14745978,[],CHEMBL3294038,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase holoenzyme using pBR322 DNA as substrate assessed as linear DNA level at 0.02 to 11 uM after 60 mins by cleavable complex assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2118300,,1,0,,,Inhibition,%,,,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,INH,,UO_0000187,,
51533,,,14745990,[],CHEMBL3294044,Bactericidal activity against Mycobacterium tuberculosis infected in human THP1 cells at 1 ug/ml for 7 days,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2118300,=,1,0,=,,LCK,,,2.3,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,LCK,,,,2.3
51534,,,14746001,[],CHEMBL3291881,"Ratio of MIC for 5-(((3S,4R)-3-Fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA D89N mutant to MIC for wild-type Mycobacterium tuberculosis H37Rv ATCC 27294",F,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2118300,=,1,0,=,,Ratio,,,16.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,16.0
51535,,,14746039,[],CHEMBL3291876,"Antimycobacterial activity against 2-oxo-1-(2-(4-((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino)piperidin-1-yl)ethyl)-1,2-dihydroquinoline-7-carbonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA A74V mutant",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118300,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.06
51536,,,14746048,[],CHEMBL3291877,"Antimycobacterial activity against 5-(((3S,4R)-3-Fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA D89N mutant",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118300,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.0
51537,,,14746057,[],CHEMBL3291878,Antimycobacterial activity against moxifloxacin-resistant Mycobacterium tuberculosis harboring DNA gyraseA G88N mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3286091,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118300,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,4.0
51538,,"""A1 Functional Group: Carboxylic acid; Ionisation Formula: A1B2 (Functional Group: the part of the molecule the pKa refers to; Ionisation formula: AxBy where 'A' refers to acidic centers within the molecule that are appreciably ionised at a pH <= 11 and 'x' equals 0, 1 or 2; and 'B' refers to basic centers within the molecule that are appreciably ionised at a pH >= 2 and 'y' equals 0, 1, 2 or 3).""",14759377,[],CHEMBL3301375,ASTRAZENECA: Most acidic pKa value (pKa A1) determined by absorption and potentiometric titration using standard methodology from Sirius Analytical. Experimental range Acids: <= 11.,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3301361,,,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2132438,,27,0,,,pKa_A1,,,6.31,CHEMBL2362975,,No relevant target,,,,pKa_A1,,,,6.31
51539,,,14760463,[],CHEMBL3301369,"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.",A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3301361,,,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2132438,,27,1,,,PPB,%,,23.19,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,23.19
51540,,,14760487,[],CHEMBL3301365,"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.",A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3301361,,,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2132438,,27,1,,,PPB,%,,30.88,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,30.88
51541,,,14760506,[],CHEMBL3301366,"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.",A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3301361,,,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2132438,,27,1,,,PPB,%,,34.42,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,34.42
51542,,,14767441,[],CHEMBL3301363,"ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured  by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3301361,,,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2132438,,27,1,,,LogD7.4,,,-0.18,CHEMBL2362975,,No relevant target,,,,LogD7.4,,,,-0.18
51543,,"""B1 Functional Group: Piperidine; Ionisation Formula: A1B2 (Functional Group: the part of the molecule the pKa refers to; Ionisation formula: AxBy where 'A' refers to acidic centers within the molecule that are appreciably ionised at a pH <= 11 and 'x' equals 0, 1 or 2; and 'B' refers to basic centers within the molecule that are appreciably ionised at a pH >= 2 and 'y' equals 0, 1, 2 or 3).""",14768489,[],CHEMBL3301362,ASTRAZENECA: Most basic pKa value (pKa B1) determined by absorption and potentiometric titration using standard methodology from Sirius Analytical. Experimental range Bases: >= 2.,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3301361,,,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2132438,,27,0,,,pKa_B1,,,9.51,CHEMBL2362975,,No relevant target,,,,pKa_B1,,,,9.51
51544,,"""B2 Functional Group: Pyrollidine; Ionisation Formula: A1B2 (Functional Group: the part of the molecule the pKa refers to; Ionisation formula: AxBy where 'A' refers to acidic centers within the molecule that are appreciably ionised at a pH <= 11 and 'x' equals 0, 1 or 2; and 'B' refers to basic centers within the molecule that are appreciably ionised at a pH >= 2 and 'y' equals 0, 1, 2 or 3).""",14770312,[],CHEMBL3301373,ASTRAZENECA: Second most basic pKa value (pKa B2) determined by absorption and potentiometric titration using standard methodology from Sirius Analytical. Experimental range Bases: >= 2.,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3301361,,,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2132438,,27,0,,,pKa_B2,,,2.72,CHEMBL2362975,,No relevant target,,,,pKa_B2,,,,2.72
51545,,,15004906,[],CHEMBL3364655,Inhibition of Mycobacterium tuberculosis GyrA/GyrB using relaxed pBR322 as substrate after 30 mins by DNA supercoiling assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351599,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.95,0,http://www.openphacts.org/units/Nanomolar,2268232,=,1,1,=,,IC50,nM,,11200.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,11.2
51546,,,15004973,[],CHEMBL3364656,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351599,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2268232,=,1,1,=,,MIC,nM,,1200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.2
51547,,Not Determined,15005016,[],CHEMBL3364657,Cytotoxicity against mouse RAW264.7 cells at 100 uM after 48 hrs by MTT assay,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351599,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2268232,,1,0,,,Inhibition,%,,,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,INH,,UO_0000187,,
51548,,,15038109,[],CHEMBL3366298,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase A2B2 holoenzyme supercoiling activity using relaxed pBR322 substrate incubated for 90 mins by ethidium bromide staining based gel electrophoresis method,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352071,ACS Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.9,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,,IC50,nM,,12500.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,12.5
51549,,,15038126,[],CHEMBL3366299,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352071,ACS Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,,MIC,nM,,130.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.13
51550,,,15038189,[],CHEMBL3366647,"Antimicrobial activity against 2-oxo-1-(2-(4-((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino)piperidin-1-yl)ethyl)-1,2-dihydroquinoline-7-carbonitrile resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase A74V mutant",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352071,ACS Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,,MIC,nM,,250.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.25
51551,,,15038200,[],CHEMBL3366648,"Antimicrobial activity against 5-(((3S,4R)-3-fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase D89N mutant",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352071,ACS Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,,MIC,nM,,2000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,2.0
51552,,,15038211,[],CHEMBL3366649,Antimicrobial activity against moxicillin resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase G88N mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352071,ACS Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,,MIC,nM,,4000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.0
51553,,,15040526,[],CHEMBL3370006,Antimycobacterial activity against Mycobacterium abscessus ATCC 19977 in 7H9 medium after 3 days and 4 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,,MIC,nM,,22400.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,uM,UO_0000065,,22.4
51554,,,15040537,[],CHEMBL3370007,Antimycobacterial activity against Mycobacterium chelonae ATCC 35752 in 7H9 medium after 3 days and 4 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,,MIC,nM,,240.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,uM,UO_0000065,,0.24
51555,,,15040549,[],CHEMBL3370008,Antimycobacterial activity against Mycobacterium marinum ATCC 927 in 7H9 medium after 5 days and 6 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,,MIC,nM,,12400.0,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,MIC,uM,UO_0000065,,12.4
51556,,,15040559,[],CHEMBL3370009,Antimycobacterial activity against Mycobacterium avium ATCC 15769 in 7H9 medium after 6 days and 18 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,,MIC,nM,,6100.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,uM,UO_0000065,,6.1
51557,,,15040571,[],CHEMBL3370010,Antimycobacterial activity against Mycobacterium kansasii ATCC 12478 in 7H9 medium after 6 days and 18 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,,MIC,nM,,120.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,uM,UO_0000065,,0.12
51558,,,15040581,[],CHEMBL3370011,Antimycobacterial activity against Mycobacterium bovis BCG ATCC 35734 in 7H12 medium after 6 days and 18 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,,MIC,nM,,60.0,CHEMBL615052,Mycobacterium tuberculosis variant bovis BCG,Mycobacterium tuberculosis variant bovis BCG,33892.0,,,MIC,uM,UO_0000065,,0.06
51559,,,15041236,[],CHEMBL3366088,Antimicrobial activity against first mutant generation Mycobacterium tuberculosis 1024_1 assessed as fold shift in MIC relative to parent strain,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351699,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2255017,=,1,0,=,,Ratio,,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Ratio,,,,1.0
51560,,,15041244,[],CHEMBL3366089,Antimicrobial activity against first mutant generation Mycobacterium tuberculosis 1024_18 assessed as fold shift in MIC relative to parent strain,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351699,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2255017,=,1,0,=,,Ratio,,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Ratio,,,,1.0
51561,,,15041253,[],CHEMBL3366090,Antimicrobial activity against second mutant generation Mycobacterium tuberculosis 1024_18 assessed as fold shift in MIC relative to parent strain,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351699,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2255017,=,1,0,=,,Ratio,,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Ratio,,,,0.5
51562,,,15041261,[],CHEMBL3366091,Antimicrobial activity against second mutant generation Mycobacterium tuberculosis 1024_8.12 assessed as fold shift in MIC relative to parent strain,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351699,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2255017,=,1,0,=,,Ratio,,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Ratio,,,,1.0
51563,,,15041269,[],CHEMBL3366092,Antimicrobial activity against second mutant generation Mycobacterium tuberculosis 1024_16.5 assessed as fold shift in MIC relative to parent strain,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351699,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2255017,=,1,0,=,,Ratio,,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Ratio,,,,1.0
51564,,,15041277,[],CHEMBL3366093,Antimicrobial activity against second mutant generation Mycobacterium tuberculosis 1024_16.6 assessed as fold shift in MIC relative to parent strain,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351699,J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2255017,=,1,0,=,,Ratio,,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Ratio,,,,1.0
51565,,,15067026,[],CHEMBL3385759,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
51566,,,15067057,[],CHEMBL3385760,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-15 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
51567,,,15067088,[],CHEMBL3385761,Antibacterial activity against Klebsiella pneumoniae 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.015
51568,,,15067119,[],CHEMBL3385762,Antibacterial activity against Klebsiella pneumoniae 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
51569,,,15067150,[],CHEMBL3385763,Antibacterial activity against Klebsiella pneumoniae 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
51570,,,15067181,[],CHEMBL3385764,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
51571,,,15067212,[],CHEMBL3385765,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
51572,,,15067243,[],CHEMBL3385766,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-7 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
51573,,,15067274,[],CHEMBL3385767,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
51574,,,15067305,[],CHEMBL3385768,Antibacterial activity against Pseudomonas aeruginosa 12-12 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
51575,,,15071834,[],CHEMBL3385769,Antibacterial activity against Pseudomonas aeruginosa 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51576,,,15071865,[],CHEMBL3385770,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51577,,,15071896,[],CHEMBL3385771,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
51578,,,15071927,[],CHEMBL3385772,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51579,,,15071958,[],CHEMBL3385773,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51580,,,15071989,[],CHEMBL3385774,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-5 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
51581,,,15072020,[],CHEMBL3385775,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51582,,,15072051,[],CHEMBL3385776,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51583,,,15072082,[],CHEMBL3385777,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-5 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51584,,,15076602,[],CHEMBL3386333,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.03
51585,,,15076633,[],CHEMBL3386334,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
51586,,,15076664,[],CHEMBL3386335,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-6 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.03
51587,,,15076695,[],CHEMBL3386336,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-8 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
51588,,,15076726,[],CHEMBL3386337,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
51589,,,15076757,[],CHEMBL3386338,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-6 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
51590,,,15076788,[],CHEMBL3386339,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
51591,,,15076819,[],CHEMBL3386340,Antibacterial activity against Streptococcus pneumoniae 12-18 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
51592,,Not Determined,15079504,[],CHEMBL3364658,"Selectivity index, ratio of CC50 for mouse RAW264.7 cells to MIC for Mycobacterium tuberculosis H37Rv",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351599,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2268232,,1,0,,,Selectivity Index,,,,CHEMBL612545,,Unchecked,,,,Selectivity Index,,,,
51593,,,15079547,[],CHEMBL3364659,Inhibition of Mycobacterium tuberculosis GyrA/GyrB using relaxed pBR322 as substrate at 0.97 uM after 30 mins by DNA supercoiling assay,B,,,BAO_0000201,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351599,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2268232,>,1,1,>,,Inhibition,%,,60.0,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,60.0
51594,,,15105474,[],CHEMBL3386589,Inhibition of Mycobacterium tuberculosis DNA gyrase-mediated relaxed pBR322 DNA supercoiling by gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3351608,ACS Med Chem Lett,2014.0,"{'bei': '12.46', 'le': '0.24', 'lle': '2.63', 'sei': '5.97'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.0,0,http://www.openphacts.org/units/Nanomolar,2247307,=,1,1,=,,IC50,nM,,10000.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,10.0
51595,,,15112914,[],CHEMBL3367585,Inhibition of Mycobacterium tuberculosis DNA gyrase supercoiling activity using relaxed pBR322 substrate incubated for 30 mins by ethidium bromide staining method,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352198,Bioorg Med Chem,2014.0,"{'bei': '12.68', 'le': '0.24', 'lle': '2.72', 'sei': '6.08'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.09,0,http://www.openphacts.org/units/Nanomolar,2246975,=,1,1,=,,IC50,nM,,8100.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,8.1
51596,,,15112946,[],CHEMBL3367584,Inhibition of 6-His-tagged Mycobacterium smegmatis GyrB expressed in Escherichia coli BL21 (DE3) pLysS cells incubated for 100 mins in presence of ATP by malachite green dye based ATP assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352198,Bioorg Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2246975,>,1,1,>,,IC50,nM,,50000.0,CHEMBL3085613,Mycobacterium smegmatis,DNA gyrase subunit B,1772.0,,,IC50,uM,UO_0000065,,50.0
51597,,,15112980,[],CHEMBL3367586,Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352198,Bioorg Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2246975,=,1,1,=,,MIC,nM,,8600.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,8.6
51598,,Not Determined,15113017,[],CHEMBL3367587,Cytotoxicity against mouse RAW264.7 cells assessed as inhibition of cell viability at 100 uM after 48 hrs by MTT assay,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352198,Bioorg Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2246975,,1,0,,,Inhibition,%,,,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,INH,,UO_0000187,,
51599,,,15137969,[],CHEMBL3385755,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
51600,,,15138000,[],CHEMBL3385756,Antibacterial activity against Escherichia coli 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51601,,,15138031,[],CHEMBL3385757,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
51602,,,15138062,[],CHEMBL3385758,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3352227,Eur J Med Chem,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
51603,,,15180628,[],CHEMBL3405734,Inhibition of Mycobacterium smegmatis GyrB ATPase activity expressed in Escherichia coli BL21 (DE3) pLysS cells after 100 mins by inorganic phosphate release detection based malachite green reagent assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3399993,Bioorg Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://www.openphacts.org/units/Nanomolar,2284758,>,1,1,>,,IC50,nM,,50000.0,CHEMBL3085613,Mycobacterium smegmatis,DNA gyrase subunit B,1772.0,,,IC50,uM,UO_0000065,,50.0
51604,,,15180682,[],CHEMBL3405737,Inhibition of Mycobacterium tuberculosis GyrA/GyrB using relaxed pBR322 substrate incubated for 30 mins by ethidium bromide staining and electrophoresis based DNA supercoiling assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3399993,Bioorg Med Chem,2015.0,"{'bei': '12.33', 'le': '0.23', 'lle': '2.58', 'sei': '5.91'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.95,0,http://www.openphacts.org/units/Nanomolar,2284758,=,1,1,=,,IC50,nM,,11200.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,11.2
51605,,,15181596,[],CHEMBL3405738,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microplate alamar blue assay method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3399993,Bioorg Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2284758,=,1,1,=,,MIC,nM,,1260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.26
51606,,Not Determined,15181648,[],CHEMBL3405739,Cytotoxicity against mouse RAW264.7 cells assessed as inhibition of cell growth at 50 uM after 48 hrs by MTT assay,A,,,BAO_0000181,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3399993,Bioorg Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2284758,,1,0,,,GI,,,,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,GI,,,,
51607,,Not Active,15205215,[],CHEMBL3411493,Inhibition of Mycobacterium tuberculosis AlaDH using L-alanine as substrate after 20 mins by spectrophotometry,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3407436,Eur J Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2289822,,1,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
51608,,,15205244,[],CHEMBL3411505,Antimycobacterial activity against dormant Mycobacterium tuberculosis H37Rv model assessed as log reduction at 10 ug/ml incubated for 7 days measured after 28 days in presence of nutrient deprived condition,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3407436,Eur J Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2289822,=,1,0,=,,FC,,,2.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,FC,,,,2.5
51609,,,15205275,[],CHEMBL3411506,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3407436,Eur J Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2289822,=,1,1,=,,MIC,nM,,1240.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.24
51610,,Not Determined,15205309,[],CHEMBL3411507,Cytotoxicity against mouse RAW264.7 cells at 50 uM after 48 hrs by MTT assay,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3407436,Eur J Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2289822,,1,0,,,Inhibition,%,,,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,INH,,UO_0000187,,
51611,,,15258028,[],CHEMBL3430707,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) K1 cells stably expressing hERG measured using IonWorks Quattro automated patch clamp platform,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2299091,=,1,1,=,,IC50,nM,,398107.17,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.4
51612,,Inactive,15258058,[],CHEMBL3430737,Inhibition of rapid delayed inward rectifying potassium current (IKr) in Chinese hamster ovary (CHO) cells stable expressing hERG measured using IonWorks Barracuda automated patch clamp platform,F,,,BAO_0000199,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2299091,,1,0,,,pIC50,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,,,
51613,,,15258088,[],CHEMBL3430338,Inhibition of rapid delayed inward rectifying potassium current (IKr) measured using manual patch clamp assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.1,0,http://www.openphacts.org/units/Nanomolar,2299091,=,1,1,=,,IC50,nM,,79432.82,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,4.1
51614,,,15258122,[],CHEMBL3430372,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2299091,=,1,1,=,,IC50,nM,,398107.17,CHEMBL1940,Homo sapiens,Voltage-gated L-type calcium channel alpha-1C subunit,9606.0,,,pIC50,,UO_0000065,,3.4
51615,,Inactive,15258152,[],CHEMBL3430402,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,F,,,BAO_0000199,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2299091,,1,0,,,pIC50,,,,CHEMBL1940,Homo sapiens,Voltage-gated L-type calcium channel alpha-1C subunit,9606.0,,,pIC50,,,,
51616,,,15258182,[],CHEMBL3430432,Inhibition of fast sodium current (INa) in Chinese Hamster Ovary (CHO) K1 cells transfected with human Nav1.5 measured using IonWorks Quattro automated patch clamp platform,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.4,0,http://www.openphacts.org/units/Nanomolar,2299091,=,1,1,=,,IC50,nM,,39810.72,CHEMBL1980,Homo sapiens,Sodium channel protein type V alpha subunit,9606.0,,,pIC50,,UO_0000065,,4.4
51617,,,15258212,[],CHEMBL3430462,Inhibition of fast sodium current (INa) in HEK293 cells transfected with human Nav1.5 measured using IonWorks Quattro automated patch clamp platform,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2299091,=,1,1,=,,IC50,nM,,251188.64,CHEMBL1980,Homo sapiens,Sodium channel protein type V alpha subunit,9606.0,,,pIC50,,UO_0000065,,3.6
51618,,,15258242,[],CHEMBL3430492,Inhibition of slow delayed inward rectifying potassium current (Iks) in Chinese Hamster Ovary (CHO) cells expressing hKvLQT1/hminK measured using IonWorks Quattro automated patch clamp platform,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2299091,=,1,1,=,,IC50,nM,,158489.32,CHEMBL2221347,Homo sapiens,"Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK)",9606.0,,,pIC50,,UO_0000065,,3.8
51619,,,15258272,[],CHEMBL3430522,Inhibition of slow delayed inward rectifying potassium current (Iks) in Chinese Hamster Ovary (CHO) cells transfected with KCNQ1 / Kv1.7 / KvLQT1 and KCNE1/minK measured using IonWorks automated patch clamp platform,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2299091,=,1,1,=,,IC50,nM,,398107.17,CHEMBL2221347,Homo sapiens,"Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK)",9606.0,,,pIC50,,UO_0000065,,3.4
51620,,Inactive,15258302,[],CHEMBL3430552,Inhibition of transient outward potassium current (Ito) current in Chinese Hamster Ovary (CHO) K1 cells expressing human Kv4.3 measured using IonWorks Quattro automated patch clamp platform,F,,,BAO_0000199,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3430320,J Pharmacol Toxicol Methods,2014.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2299091,,1,0,,,pIC50,,,,CHEMBL1964,Homo sapiens,Voltage-gated potassium channel subunit Kv4.3,9606.0,,,pIC50,,,,
51621,,,15373253,[],CHEMBL3436098,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3436046,J Appl Toxicol,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2330109,=,1,1,=,,IC50,nM,,168900.0,CHEMBL1940,Homo sapiens,Voltage-gated L-type calcium channel alpha-1C subunit,9606.0,,,IC50,uM,UO_0000065,,168.9
51622,,,15373340,[],CHEMBL3436185,"Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits",F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3436045,Sci Rep,2013.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2330166,=,1,1,=,,IC50,nM,,173000.0,CHEMBL2095229,Homo sapiens,Voltage-gated L-type calcium channel,9606.0,,,IC50,uM,UO_0000065,,173.0
51623,,,15659326,[],CHEMBL3599454,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51624,,,15659701,[],CHEMBL3599455,Antibacterial activity against Staphylococcus aureus KCTC 209 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51625,,,15659732,[],CHEMBL3599456,Antibacterial activity against Staphylococcus aureus KCTC 503 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51626,,,15659763,[],CHEMBL3599457,Antibacterial activity against Streptococcus mutans 3065 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,ug ml-1,UO_0000274,,0.25
51627,,,15659794,[],CHEMBL3599458,Antibacterial activity against Escherichia coli KCTC 1924 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51628,,,15659825,[],CHEMBL3599459,Antibacterial activity against Escherichia coli CCARM 1356 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
51629,,,15659856,[],CHEMBL3599460,Antibacterial activity against Pseudomonas aeruginosa 2742 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51630,,,15659887,[],CHEMBL3599461,Antibacterial activity against Pseudomonas aeruginosa 2004 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
51631,,,15659918,[],CHEMBL3599462,Antibacterial activity against Salmonella typhimurium 2421 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
51632,,,15659949,[],CHEMBL3599463,Antifungal activity against Candida albicans 7535 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,0.5
51633,,,15659971,[],CHEMBL3599464,Bactericidal activity against Staphylococcus aureus RN4220 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
51634,,,15660290,[],CHEMBL3599465,Bactericidal activity against Staphylococcus aureus KCTC 209 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
51635,,,15660312,[],CHEMBL3599466,Bactericidal activity against Staphylococcus aureus KCTC 503 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
51636,,,15660334,[],CHEMBL3599467,Bactericidal activity against Streptococcus mutans 3065 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MBC,ug ml-1,UO_0000274,,0.25
51637,,,15660356,[],CHEMBL3599468,Bactericidal activity against Escherichia coli KCTC 1924 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
51638,,,15660378,[],CHEMBL3599469,Fungicidal activity against Candida albicans 7535 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MFC,ug ml-1,,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MFC,ug ml-1,UO_0000274,,0.5
51639,,,15660429,[],CHEMBL3599474,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51640,,,15660460,[],CHEMBL3599475,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51641,,,15660491,[],CHEMBL3599476,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51642,,,15660522,[],CHEMBL3599591,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51643,,,15660543,[],CHEMBL3599592,Bactericidal activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
51644,,,15660564,[],CHEMBL3599593,Bactericidal activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
51645,,,15660873,[],CHEMBL3599594,Bactericidal activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,4.0
51646,,,15660894,[],CHEMBL3599595,Bactericidal activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by agar plate method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,4.0
51647,,,15689999,[],CHEMBL3610295,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608244,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,,MIC,nM,,130.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.13
51648,,,15690026,[],CHEMBL3610297,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase assessed as supercoiling of pBR322 DNA after 90 mins by agarose gel electrophoresis method,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608244,ACS Med Chem Lett,2015.0,"{'bei': '12.21', 'le': '0.23', 'lle': '2.53', 'sei': '5.85'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.9,1,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,,IC50,nM,,12500.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,12.5
51649,,,15690034,[],CHEMBL3610298,"Antimycobacterial activity against 6-((1-(2-(7-chloro-2-oxo-1,8-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA A74V mutant incubated for 7 days by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608244,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,,MIC,nM,,250.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.25
51650,,,15690042,[],CHEMBL3610299,"Antimycobacterial activity against 1-(2-(4-((5-chloro-6-methylpyridin-3-yl)methylamino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA D89N mutant incubated for 7 days by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608244,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,,MIC,nM,,2000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,2.0
51651,,,15690050,[],CHEMBL3610300,Antimycobacterial activity against moxifloxacin resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA G88N mutant incubated for 7 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608244,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,,MIC,nM,,4000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.0
51652,,,15691789,[],CHEMBL3610234,Antimicrobial activity against Staphylococcus aureus ATCC 25923 by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0625
51653,,,15691806,[],CHEMBL3610235,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51654,,,15691825,[],CHEMBL3610236,Antimicrobial activity against levofloxacin-resistant Staphylococcus aureus clinical isolates by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51655,,,15691844,[],CHEMBL3610237,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
51656,,,15691863,[],CHEMBL3610238,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
51657,,,15691882,[],CHEMBL3610239,Antimicrobial activity against Streptococcus pyogenes ATCC 19615 by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
51658,,,15691901,[],CHEMBL3610240,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,<=,1,1,<=,,MIC,ug.mL-1,,0.016,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.016
51659,,,15691920,[],CHEMBL3610307,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolates by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
51660,,,15691939,[],CHEMBL3610308,Antimicrobial activity against Escherichia coli ATCC 25922 by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.031
51661,,,15691958,[],CHEMBL3610309,Antimicrobial activity against ciprofloxacin-resistant Escherichia coli clinical isolates by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
51662,,,15691977,[],CHEMBL3610310,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
51663,,,15751109,[],CHEMBL3632234,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51664,,,15751134,[],CHEMBL3632235,Antibacterial activity against Staphylococcus aureus 209 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51665,,,15751170,[],CHEMBL3632236,Antibacterial activity against Staphylococcus aureus 503 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51666,,,15751200,[],CHEMBL3632237,Antibacterial activity against Streptococcus mutans 3065 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,ug ml-1,UO_0000274,,0.25
51667,,,15751230,[],CHEMBL3632238,Antibacterial activity against Escherichia coli KCTC 1924 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51668,,,15751553,[],CHEMBL3632239,Antibacterial activity against Escherichia coli CCARM 1356 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
51669,,,15751583,[],CHEMBL3632240,Antibacterial activity against Pseudomonas aeruginosa 2742 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51670,,,15751613,[],CHEMBL3632241,Antibacterial activity against Pseudomonas aeruginosa 2004 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
51671,,,15751643,[],CHEMBL3632242,Antibacterial activity against Salmonella typhimurium 2421 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
51672,,,15751673,[],CHEMBL3632243,Antifungal activity against Candida albicans 7535 by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,0.5
51673,,,15751701,[],CHEMBL3632244,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51674,,,15751731,[],CHEMBL3632245,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51675,,,15751761,[],CHEMBL3632246,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51676,,,15751791,[],CHEMBL3632247,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51677,,,15753249,[],CHEMBL3630322,Inhibition of DNA gyrase GyrA/GyrB in Mycobacterium tuberculosis incubated for 30 mins assessed as reduction in supercoiling of relaxed relaxed pBR322 DNA by ethidium bromide staining based agarose gel electrophoresis method,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627613,Eur J Med Chem,2015.0,"{'bei': '12.33', 'le': '0.23', 'lle': '2.58', 'sei': '5.91'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.95,1,http://www.openphacts.org/units/Nanomolar,2507504,=,1,1,=,,IC50,nM,,11200.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,11.2
51678,,,15753319,[],CHEMBL3630438,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition incubated for 7 days by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627613,Eur J Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2507504,=,1,1,=,,MIC,nM,,1260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.26
51679,,Not Determined,15753324,[],CHEMBL3630439,Cytotoxicity against mouse RAW264.7 cells assessed as inhibition of cell viability at 50 uM incubated for 48 hrs at 37 degC by MTT assay relative to control,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627613,Eur J Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2507504,,1,0,,,Inhibition,%,,,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,INH,,UO_0000187,,
51680,,,15753729,[],CHEMBL3630319,Inhibition of Mycobacterium smegmatis DNA gyrase B expressed in Escherichia coli BL21 (DE3) pLysS cells assessed as reduction in ATPase activity incubated for 100 mins by inorganic phosphate detection assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3627613,Eur J Med Chem,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://www.openphacts.org/units/Nanomolar,2507504,>,1,1,>,,IC50,nM,,50000.0,CHEMBL3085613,Mycobacterium smegmatis,DNA gyrase subunit B,1772.0,,,IC50,uM,UO_0000065,,50.0
51681,,,15763160,[],CHEMBL3637176,Antibacterial activity against Pseudomonas aeruginosa 14-14 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51682,,,15763181,[],CHEMBL3637177,Antibacterial activity against Pseudomonas aeruginosa 14-15 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51683,,,15763202,[],CHEMBL3637178,Antibacterial activity against Pseudomonas aeruginosa 14-16 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
51684,,,15763223,[],CHEMBL3637179,Antibacterial activity against Pseudomonas aeruginosa 14-19 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51685,,,15763244,[],CHEMBL3637180,Antibacterial activity against Staphylococcus aureus CMCC 26003 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
51686,,,15763265,[],CHEMBL3637181,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-1 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51687,,,15763286,[],CHEMBL3637182,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-2 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
51688,,,15763307,[],CHEMBL3637183,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-3 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51689,,,15763328,[],CHEMBL3637184,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-4 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51690,,,15763349,[],CHEMBL3637185,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-4 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
51691,,,15763370,[],CHEMBL3637186,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-5 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51692,,,15763391,[],CHEMBL3637187,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-2 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
51693,,,15763412,[],CHEMBL3637320,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-21 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
51694,,,15763433,[],CHEMBL3637321,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-22 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
51695,,,15764054,[],CHEMBL3637322,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-37 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
51696,,,15764075,[],CHEMBL3637323,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-39 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
51697,,,15764096,[],CHEMBL3637324,Antibacterial activity against Streptococcus pneumoniae ATCC 19615 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
51698,,,15764117,[],CHEMBL3637325,Antibacterial activity against Enterococcus faecalis 14-1 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,32.0
51699,,,15764138,[],CHEMBL3635097,Antibacterial activity against Enterococcus faecalis 14-2 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
51700,,,15764159,[],CHEMBL3635098,Antibacterial activity against Enterococcus faecium 14-1 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
51701,,,15764180,[],CHEMBL3635099,Antibacterial activity against Enterococcus faecium 14-2 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
51702,,,15764201,[],CHEMBL3635100,Antibacterial activity against Enterococcus faecium 14-5 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
51703,,,15764222,[],CHEMBL3635101,Antibacterial activity against Enterococcus faecium 14-6 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
51704,,,15776051,[],CHEMBL3637162,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
51705,,,15776072,[],CHEMBL3637163,Antibacterial activity against ESBL-positive Escherichia coli 14-1 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51706,,,15776093,[],CHEMBL3637164,Antibacterial activity against ESBL-positive Escherichia coli 14-2 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
51707,,,15776114,[],CHEMBL3637165,Antibacterial activity against Escherichia coli 14-1 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
51708,,,15776135,[],CHEMBL3637166,Antibacterial activity against Escherichia coli 14-2 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
51709,,,15776156,[],CHEMBL3637167,Antibacterial activity against ESBL-positive Klebsiella pneumoniae 14-17 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
51710,,,15776177,[],CHEMBL3637168,Antibacterial activity against ESBL-positive Klebsiella pneumoniae 14-18 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
51711,,,15776198,[],CHEMBL3637169,Antibacterial activity against ESBL-positive Klebsiella pneumoniae 14-19 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
51712,,,15776219,[],CHEMBL3637170,Antibacterial activity against Klebsiella pneumoniae 14-1 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
51713,,,15776240,[],CHEMBL3637171,Antibacterial activity against Klebsiella pneumoniae 14-2 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
51714,,,15776261,[],CHEMBL3637172,Antibacterial activity against Klebsiella pneumoniae 14-3 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
51715,,,15776282,[],CHEMBL3637173,Antibacterial activity against Klebsiella pneumoniae 14-4 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
51716,,,15776303,[],CHEMBL3637174,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
51717,,,15776324,[],CHEMBL3637175,Antibacterial activity against Pseudomonas aeruginosa 14-9 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
51718,,Not Determined,16410570,[],CHEMBL3745475,Antibacterial activity against Staphylococcus aureus 1118 infected in sc and iv dosed mouse assessed as septicemia compound administered 1 hr post-infection twice for 1 day measured for 7 days,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2738044,,1,0,,,PD50,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,,,,
51719,,,16410575,[],CHEMBL3745484,Antibacterial activity against Streptococcus pneumoniae 402 infected in sc dosed mouse assessed as reduction in 2 log CFU in lung compound administered as BID for 1 day measured 24 hrs after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2738044,=,1,0,=,,ED,mg kg-1,,28.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED,mg kg-1,UO_0000308,,28.6
51720,,,16410580,[],CHEMBL3745485,Antibacterial activity against Streptococcus pneumoniae 402 infected in sc dosed mouse assessed as reduction in 3 log CFU in lung compound administered as BID for 1 day measured 24 hrs after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2738044,=,1,0,=,,ED,mg kg-1,,50.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED,mg kg-1,UO_0000308,,50.8
51721,,Not Determined,16410585,[],CHEMBL3745486,"Dose-normalized AUC in mouse at 2 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2738044,,1,0,,,AUC/dose,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC/dose,,,,
51722,,Not Determined,16410590,[],CHEMBL3745487,"Volume of distribution at steady state in mouse at 2 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2738044,,1,0,,,Vdss,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Vdss,,,,
51723,,Not Determined,16410595,[],CHEMBL3745488,"Half-life in mouse at 2 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2738044,,1,0,,,t1/2,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,,,,
51724,,Not Determined,16410600,[],CHEMBL3745489,"Clearance in mouse at 2 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2738044,,1,0,,,CL,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CL,,,,
51725,,Not Determined,16410605,[],CHEMBL3745479,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1118 for 18 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2738044,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
51726,,,16410606,[],CHEMBL3745481,Antibacterial activity against Streptococcus pneumoniae for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739399,ACS Med Chem Lett,2015.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2738044,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
51727,,,16413966,[],CHEMBL3745429,Inhibition of Mycobacterium tuberculosis DNA gyrase assessed as inhibition of supercoiling activity using relaxed pBR322 plasmid as substrate after 30 mins,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739357,Bioorg Med Chem,2016.0,"{'bei': '12.33', 'le': '0.23', 'lle': '2.58', 'sei': '5.91'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.95,1,http://www.openphacts.org/units/Nanomolar,2738465,=,1,1,=,,IC50,nM,,11200.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,11.2
51728,,,16414003,[],CHEMBL3745430,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739357,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2738465,=,1,1,=,,MIC,nM,,2400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,2.4
51729,,Not Determined,16414038,[],CHEMBL3745431,Cytotoxicity against mouse RAW264.7 cells at 50 uM after 48 hrs by MTT assay,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3739357,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2738465,,1,0,,,Inhibition,%,,,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,INH,,UO_0000187,,
51730,,,16447540,[],CHEMBL3758003,Inhibition of Mycobacterium tuberculosis DNA gyrase assessed as inhibition of DNA supercoiling after 30 mins by electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3751721,Bioorg Med Chem,2016.0,"{'bei': '12.33', 'le': '0.23', 'lle': '2.58', 'sei': '5.91'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.95,1,http://www.openphacts.org/units/Nanomolar,2745725,=,1,1,=,,IC50,nM,,11200.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,11.2
51731,,,16448689,[],CHEMBL3758010,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3751721,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2745725,=,1,1,=,,MIC,nM,,1260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.26
51732,,,16448729,[],CHEMBL3758011,Cytotoxicity against mouse RAW264.7 cells assessed as inhibition of cell growth at 50 uM after 72 hrs by MTT assay,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3751721,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2745725,=,1,1,=,,Inhibition,%,,1.26,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,INH,%,UO_0000187,,1.26
51733,,,16471644,[],CHEMBL3766327,"Antimycobacterial activity against Mycobacterium marinum ATCC BAA-535 infected in Zebra fish model assessed as reduction in bacterial load at 5 mg/kg, po administered for 7 days measured after 14 days by MPN assay",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3763117,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2756857,=,1,0,=,,Activity,deltalog10CFU/ml,,2.9,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,Activity,deltalog10CFU/ml,,,2.9
51734,,,16471647,[],CHEMBL3766333,Antimycobacterial activity against nutrient starved Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial load for 7 days measured after 28 days by microplate reader analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3763117,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756857,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.78
51735,,,16554955,[],CHEMBL3794984,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae TPS3 after 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3792299,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2770359,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
51736,,Not Active,16554991,[],CHEMBL3795079,"Antibacterial activity against quinolone-resistant Streptococcus pneumoniae TPS3 in rat respiratory tract infection model assessed as decrease in bacterial burden in lung at 100 mg/kg, po bid administered through gavage at 1, 7, 24,31 hrs post infection measured after 48 hrs",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3792299,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2770359,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
51737,,,16561084,[],CHEMBL3802071,Antibacterial activity against Staphylococcus aureus CMCC 26003 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
51738,,,16561102,[],CHEMBL3802072,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
51739,,,16561120,[],CHEMBL3802073,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-3 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51740,,,16561138,[],CHEMBL3802074,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-4 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
51741,,,16561156,[],CHEMBL3802075,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-4 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.0
51742,,,16561174,[],CHEMBL3802076,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-5 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
51743,,,16561192,[],CHEMBL3802077,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
51744,,,16561210,[],CHEMBL3802078,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-4 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
51745,,,16561228,[],CHEMBL3802079,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-6 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
51746,,,16561246,[],CHEMBL3802080,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-22 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
51747,,,16561264,[],CHEMBL3803900,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-37 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
51748,,,16561282,[],CHEMBL3803901,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-39 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
51749,,,16561300,[],CHEMBL3803902,Antibacterial activity against Streptococcus pneumoniae ATCC 19615 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
51750,,,16561318,[],CHEMBL3803903,Antibacterial activity against Enterococcus faecium 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,32.0
51751,,,16561336,[],CHEMBL3803904,Antibacterial activity against Enterococcus faecium 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.5
51752,,,16561354,[],CHEMBL3803905,Antibacterial activity against Enterococcus faecalis 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
51753,,,16562255,[],CHEMBL3803906,Antibacterial activity against Enterococcus faecalis 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
51754,,,16562273,[],CHEMBL3803907,Antibacterial activity against Enterococcus faecalis 14-3 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
51755,,,16578101,[],CHEMBL3801853,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
51756,,,16578119,[],CHEMBL3801854,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51757,,,16579005,[],CHEMBL3801855,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
51758,,,16579023,[],CHEMBL3801856,Antibacterial activity against Escherichia coli 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
51759,,,16579041,[],CHEMBL3802057,Antibacterial activity against Escherichia coli 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
51760,,,16579059,[],CHEMBL3802058,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae 14-17 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
51761,,,16579077,[],CHEMBL3802059,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae 14-18 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
51762,,,16579095,[],CHEMBL3802060,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae 14-19 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
51763,,,16579113,[],CHEMBL3802061,Antibacterial activity against Klebsiella pneumoniae 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
51764,,,16579131,[],CHEMBL3802062,Antibacterial activity against Klebsiella pneumoniae 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
51765,,,16579149,[],CHEMBL3802063,Antibacterial activity against Klebsiella pneumoniae 14-3 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
51766,,,16579167,[],CHEMBL3802064,Antibacterial activity against Klebsiella pneumoniae 14-4 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
51767,,,16579185,[],CHEMBL3802065,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
51768,,,16579203,[],CHEMBL3802066,Antibacterial activity against Pseudomonas aeruginosa 14-9 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
51769,,,16579221,[],CHEMBL3802067,Antibacterial activity against Pseudomonas aeruginosa 14-14 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51770,,,16579239,[],CHEMBL3802068,Antibacterial activity against Pseudomonas aeruginosa 14-15 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51771,,,16579257,[],CHEMBL3802069,Antibacterial activity against Pseudomonas aeruginosa 14-16 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
51772,,,16579275,[],CHEMBL3802070,Antibacterial activity against Pseudomonas aeruginosa 14-19 after 18 to 24 hrs by CLSI M100-S11 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51773,,,16607675,[],CHEMBL3812637,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 42 incubated for 18 to 24 hrs by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3808315,ACS Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2779541,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
51774,,,16649292,[],CHEMBL3830493,Antibacterial activity against nutrient-starved dormant Mycobacterium tuberculosis H37Rv assessed in log reduction in bacterial count at 10 ug/ml measured after 7 days by MPN assay relative to control,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3826950,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2788872,=,1,0,=,,FC,,,2.8,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,FC,,,,2.8
51775,,,16649309,[],CHEMBL3830494,Antibacterial activity against actively replicative Mycobacterium tuberculosis H37Rv measured after 7 days by MABA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3826950,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2788872,=,1,1,=,,MIC,nM,,1240.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.24
51776,,,16672630,[],CHEMBL3855799,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by MABA,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3853352,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2797270,=,1,1,=,,MIC,nM,,1260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.26
51777,,,16672664,[],CHEMBL3855800,Antimycobacterial activity against dormant stage of Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth under nutrient starved conditions at 10 ug/ml for 7 days measured after 28 days,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3853352,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2797270,=,1,0,=,,FC,,,2.7,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,FC,,,,2.7
51778,,,16672733,[],CHEMBL3855802,Inhibition of Mycobacterium tuberculosis ADH assessed as decrease in conversion of L-alanine to pyruvate by measuring NADH by spectrophotometry,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3853352,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2797270,>,1,1,>,,IC50,nM,,25000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,25.0
51779,,Not Determined,16672771,[],CHEMBL3855804,Cytotoxicity against mouse RAW264.7 cells assessed as inhibition of cell proliferation at 50 ug/ml after 48 hrs by MTT assay,T,,,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3853352,Bioorg Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2797270,,1,0,,,Inhibition,%,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,INH,,UO_0000187,,
51780,,,16743506,[],CHEMBL3858077,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51781,,,16743512,[],CHEMBL3858078,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51782,,,16743518,[],CHEMBL3858079,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis isolate CANWARD-2008 81388 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
51783,,,16743524,[],CHEMBL3858080,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate CAN-ICU 61589 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,64.0
51784,,,16743530,[],CHEMBL3858081,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
51785,,,16743536,[],CHEMBL3858082,Antibacterial activity against Enterococcus faecium ATCC 27270 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
51786,,,16743542,[],CHEMBL3858083,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
51787,,,16743548,[],CHEMBL3858084,Antibacterial activity against gentamicin-resistant Escherichia coli isolate CAN-ICU 61714 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
51788,,,16743554,[],CHEMBL3858085,Antibacterial activity against amikacin-resistant Escherichia coli isolate CAN-ICU 63074 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
51789,,,16743560,[],CHEMBL3858086,Antibacterial activity against gentamicin/tobramycin/ciprofloxacin-resistant Escherichia coli isolate CANWARD-2011 97615 harboring AAC3-2A after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
51790,,,16743566,[],CHEMBL3858087,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
51791,,,16743572,[],CHEMBL3858088,Antibacterial activity against gentamicin-resistant Pseudomonas aeruginosa isolate CAN-ICU 62308 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51792,,,16743578,[],CHEMBL3858089,Antibacterial activity against gentamicin/tobramycin-resistant Pseudomonas aeruginosa isolate CANWARD-2011 96846 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51793,,,16743584,[],CHEMBL3858090,Antibacterial activity against Stenotrophomonas maltophilia isolate CAN-ICU 62584 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,4.0
51794,,,16743590,[],CHEMBL3858091,Antibacterial activity against Acinetobacter baumannii isolate CAN-ICU 63169 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
51795,,,16743596,[],CHEMBL3858092,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
51796,,,16743606,[],CHEMBL3858093,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 100036,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
51797,,,16743618,[],CHEMBL3858094,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 101885,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
51798,,,16743630,[],CHEMBL3858095,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 259-96918,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
51799,,,16743642,[],CHEMBL3858096,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 260-97103,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,64.0,32.0
51800,,,16743654,[],CHEMBL3858097,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 262-101856,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,128.0,64.0
51801,,,16743666,[],CHEMBL3858098,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 264-104354,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,64.0,32.0
51802,,,16743678,[],CHEMBL3858099,Antibacterial activity against pandrug-resistant Pseudomonas aeruginosa isolate 91433,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,16.0,8.0
51803,,,16743690,[],CHEMBL3858100,Antibacterial activity against pandrug-resistant Pseudomonas aeruginosa isolate 101243,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
51804,,,16743702,[],CHEMBL3858101,Antibacterial activity against Pseudomonas aeruginosa PAO1,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51805,,,16743710,[],CHEMBL3858076,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86052,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51806,,,16743720,[],CHEMBL3858102,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86053,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51807,,,16743730,[],CHEMBL3858103,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86067,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51808,,,16743740,[],CHEMBL3858104,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86079,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51809,,,16743750,[],CHEMBL3858105,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86141,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51810,,,16743760,[],CHEMBL3858106,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 92014,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51811,,,16743770,[],CHEMBL3858107,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 108590,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51812,,,16743780,[],CHEMBL3858108,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 79199,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51813,,,16743790,[],CHEMBL3858109,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 80621,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
51814,,,16743800,[],CHEMBL3858110,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 83182,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51815,,,16743810,[],CHEMBL3858111,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 84745,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
51816,,,16743820,[],CHEMBL3858112,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 85322,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
51817,,,16743830,[],CHEMBL3858113,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by microtitre broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
51818,,,16743857,[],CHEMBL3858138,Antibacterial activity against extremely drug-resistant Pseudomonas aeruginosa isolate 104354 infected in Galleria mellonella assessed as larvae survival at 50 mg/kg administered as single dose measured after 24 hrs (Rvb = 27 %),F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2798634,=,1,0,=,,Survival,%,,27.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Survival,%,UO_0000187,,27.0
51819,,,16743860,[],CHEMBL3858139,Antibacterial activity against extremely drug-resistant Pseudomonas aeruginosa isolate 104354 infected in Galleria mellonella assessed as larvae survival at 75 mg/kg administered as single dose measured after 96 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2798634,=,1,0,=,,Survival,%,,7.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Survival,%,UO_0000187,,7.0
51820,,,16743904,[],CHEMBL3858180,Induction of cytoplasmic membrane depolarization in Pseudomonas aeruginosa PAO1 at 1 ug/ml by DiSC3(5) dye based fluorescence assay,F,,,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2798634,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
51821,,,16743907,[],CHEMBL3858182,Antimicrobial activity against Pseudomonas aeruginosa PAO200,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
51822,,,16743909,[],CHEMBL3858183,Antimicrobial activity against Pseudomonas aeruginosa PAO750,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,,MIC,ug.mL-1,,0.0078,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.0078
51823,,,16743910,[],CHEMBL3858184,Selectivity ratio of MIC for Pseudomonas aeruginosa PAO1 to MIC for Pseudomonas aeruginosa PAO200,F,,,BAO_0002136,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2798634,=,1,0,=,,Selectivity ratio,,,4.0,CHEMBL612545,,Unchecked,,,,Selectivity ratio,,,,4.0
51824,,,16743912,[],CHEMBL3858185,Selectivity ratio of MIC for Pseudomonas aeruginosa PAO1 to MIC for Pseudomonas aeruginosa PAO750,F,,,BAO_0002136,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2798634,=,1,0,=,,Selectivity ratio,,,128.0,CHEMBL612545,,Unchecked,,,,Selectivity ratio,,,,128.0
51825,,,16743922,[],CHEMBL3858191,Inhibition of Pseudomonas aeruginosa DNA gyrase A assessed as inhibition of DNA supercoiling using PBR322 DNA as substrate after 30 mins by SYBR Gold staining based agarose gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.58,0,http://www.openphacts.org/units/Nanomolar,2798634,=,1,1,=,,IC50,nM,,2600.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,2.6
51826,,,16743924,[],CHEMBL3858192,Ratio of MIC for Pseudomonas aeruginosa PAO1 after 25 serial passages to MIC for Pseudomonas aeruginosa PAO1 prior to 25 serial passages,F,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3856229,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2798634,=,1,0,=,,Ratio,,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Ratio,,,,16.0
51827,,,16804654,[],CHEMBL3869887,Antibacterial activity against Salmonella typhimurium 1926 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809485,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
51828,,,16804656,[],CHEMBL3869888,Antibacterial activity against Pseudomonas aeruginosa 2742 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809485,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51829,,,16804669,[],CHEMBL3869881,Antibacterial activity against Staphylococcus aureus 503 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809485,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51830,,,16804673,[],CHEMBL3869883,Antibacterial activity against Staphylococcus aureus 209 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809485,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51831,,,16804675,[],CHEMBL3869884,Antibacterial activity against Streptococcus mutans 3065 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809485,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,ug ml-1,UO_0000274,,0.25
51832,,,16804676,[],CHEMBL3869882,Antibacterial activity against Staphylococcus aureus 4220 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809485,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51833,,Not Determined,16804682,[],CHEMBL3869889,Antifungal activity against Candida albicans 7535 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,2809485,,1,0,,,MIC,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,,,,
51834,,,16804696,[],CHEMBL3869886,Antibacterial activity against Escherichia coli 1356 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809485,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
51835,,,16804862,[],CHEMBL3869885,Antibacterial activity against Escherichia coli 1924 measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3868618,Bioorg Med Chem Lett,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809485,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51836,,,17976834,[],CHEMBL3997267,Antibacterial activity against Escherichia coli ATCC 25922 incubated after 24 hrs by resazurin dye based broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,<=,1,1,<=,,MIC90,ug.mL-1,,1.95,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,1.95
51837,,,17976849,[],CHEMBL3997266,Antibacterial activity against Escherichia coli ATCC 35218 incubated after 24 hrs by resazurin dye based broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,<=,1,1,<=,,MIC90,ug.mL-1,,1.95,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,1.95
51838,,,17976864,[],CHEMBL3997265,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated after 24 hrs by resazurin dye based broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,<=,1,1,<=,,MIC90,ug.mL-1,,1.95,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.95
51839,,,17976879,[],CHEMBL3997268,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 incubated after 24 hrs by resazurin dye based broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,=,1,1,=,,MIC90,ug.mL-1,,3.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,3.9
51840,,,17976894,[],CHEMBL3997269,Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated after 24 hrs by resazurin dye based broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,<=,1,1,<=,,MIC90,ug.mL-1,,1.95,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,1.95
51841,,,17976909,[],CHEMBL3997270,Antibacterial activity against Enterococcus faecalis ATCC 51299 incubated after 24 hrs by resazurin dye based broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,<=,1,1,<=,,MIC90,ug.mL-1,,1.95,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,1.95
51842,,,17976924,[],CHEMBL3997271,Antibacterial activity against Listeria monocytogenes ATCC 7644 incubated after 24 hrs by resazurin dye based broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,=,1,1,=,,MIC90,ug.mL-1,,3.9,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC90,ug ml-1,UO_0000274,,3.9
51843,,,17976939,[],CHEMBL3997272,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated after 24 hrs by resazurin dye based broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,=,1,1,=,,MIC90,ug.mL-1,,3.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,3.9
51844,,Active,17976956,[],CHEMBL3997260,Inhibition of Escherichia coli DNA gyrase assessed as inhibition of enzyme-mediated supercoiling of relaxed pHOT1 DNA substrate at 1.95 to 15.6 ug/ml after 30 mins by gel electrophoresis method,B,,,BAO_0000201,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,2978229,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
51845,,,17976959,[],CHEMBL3997277,Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell proliferation after 24 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3994650,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2978229,=,1,1,=,,IC50,ug.mL-1,,379.82,CHEMBL614822,Mus musculus,NIH3T3,10090.0,,,IC50,ug ml-1,UO_0000274,,379.82
51846,,,18005367,[],CHEMBL4003165,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin reduction microplate assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4002573,Eur J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2983648,=,1,1,=,,MIC,ug.mL-1,,0.075,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.075
51847,,,18005380,[],CHEMBL4003166,Antimycobacterial activity against Mycobacterium tuberculosis PE-003 clinical isolate after 7 days by resazurin reduction microplate assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4002573,Eur J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2983648,=,1,1,=,,MIC,nM,,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.1
51848,,,18005392,[],CHEMBL4003167,Antimycobacterial activity against Mycobacterium tuberculosis CDCT-4 (1105/09) clinical isolate after 7 days by resazurin reduction microplate assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4002573,Eur J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2983648,<,1,1,<,,MIC,nM,,450.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.45
51849,,,18017882,[],CHEMBL4005356,Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4004808,J Nat Prod,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2985651,<,1,1,<,,MIC,nM,,900.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.9
51850,,,18017896,[],CHEMBL4005357,Antibacterial activity against methicilin-resistant Staphylococcus aureus ATCC 700699 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4004808,J Nat Prod,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2985651,=,1,1,=,,MIC,nM,,3800.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,3.8
51851,,,18017910,[],CHEMBL4005358,Antibacterial activity against Enterococcus faecalis ATCC 29212 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4004808,J Nat Prod,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2985651,=,1,1,=,,MIC,nM,,900.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,0.9
51852,,,18017924,[],CHEMBL4005359,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4004808,J Nat Prod,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2985651,=,1,1,=,,MIC,nM,,900.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,0.9
51853,,,18017938,[],CHEMBL4005360,Antibacterial activity against Enterococcus faecium ATCC 35667 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4004808,J Nat Prod,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2985651,=,1,1,=,,MIC,nM,,1900.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,uM,UO_0000065,,1.9
51854,,,18017952,[],CHEMBL4005361,Antibacterial activity against Enterococcus faecium ATCC 700221 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4004808,J Nat Prod,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2985651,=,1,1,=,,MIC,nM,,7800.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,uM,UO_0000065,,7.8
51855,,,18071095,[],CHEMBL4015290,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995409,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51856,,,18071192,[],CHEMBL4015291,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 100036 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995409,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
51857,,,18071206,[],CHEMBL4015292,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 101885 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995409,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
51858,,,18071220,[],CHEMBL4015293,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P259-96918 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995409,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
51859,,,18071234,[],CHEMBL4015294,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P262-101856 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995409,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
51860,,,18071248,[],CHEMBL4015295,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P264-104354 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995409,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
51861,,,18071262,[],CHEMBL4015296,Antibacterial activity against multidrug/extremely drug-resistant/colistin-resistant Pseudomonas aeruginosa isolate 91433 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995409,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
51862,,,18071276,[],CHEMBL4015297,Antibacterial activity against multidrug/extremely drug-resistant/colistin-resistant Pseudomonas aeruginosa isolate 101243 after 18 hrs by microtiter dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4014308,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995409,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
51863,,,18080613,[],CHEMBL4017550,Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method,A,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4017441,Drug Metab Dispos,2012.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,2997507,>,1,1,>,,IC50,nM,,1000000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,1000.0
51864,,Active,18108634,[],CHEMBL4023543,"Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in C57BL6 mouse cornea assessed as decrease in conjunctival chemosis at 0.3% administered tropically 2 times on day 1, 4 times on day 2 and 2 times on day 3 starting from 6 hrs post infection measured 48 hrs post last dose by slit-lamp photography",F,,,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4020828,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3003010,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
51865,,Active,18108636,[],CHEMBL4023544,"Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in C57BL6 mouse cornea assessed as decrease in corneal infiltrates at 0.3% administered tropically 2 times on day 1, 4 times on day 2 and 2 times on day 3 starting from 6 hrs post infection measured 48 hrs post last dose by slit-lamp photography",F,,,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4020828,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3003010,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
51866,,,18108638,[],CHEMBL4023545,"Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in C57BL6 mouse cornea assessed as mean corneal thickness at 0.3% administered tropically 2 times on day 1, 4 times on day 2 and 2 times on day 3 starting from 6 hrs post infection measured 24 hrs post last dose by AS-OCT method (Rvb = 151.7 +/- 12.7 micrometer)",F,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4020828,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Micrometer,3003010,=,1,0,=,,Activity,um,,124.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,um,UO_0000017,,124.2
51867,,,18108640,[],CHEMBL4023546,"Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in C57BL6 mouse cornea assessed as mean corneal thickness at 0.3% administered tropically 2 times on day 1, 4 times on day 2 and 2 times on day 3 starting from 6 hrs post infection measured 48 hrs post last dose by AS-OCT method (Rvb = 186.2 +/- 17.5 micrometer)",F,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4020828,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Micrometer,3003010,=,1,0,=,,Activity,um,,140.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,um,UO_0000017,,140.3
51868,,,18108642,[],CHEMBL4023548,"Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in C57BL6 mouse cornea assessed as decrease in log bacterial load/tissue at 0.3% administered tropically 2 times on day 1, 4 times on day 2 and 2 times on day 3 starting from 6 hrs post infection measured 48 hrs post last dose",F,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4020828,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3003010,=,1,0,=,,Activity,log10CFU,,3.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU,,,3.7
51869,,,18132022,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3007020,=,1,0,=,,DILI_severity_class,,,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,8.0
51870,,Less-Dili-Concern,18132622,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3007020,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
51871,,,18142167,[],CHEMBL4031533,Antitubercular activity against isoniazid resistant Mycobacterium tuberculosis H37Rv ATCC 35822 after 24 hrs by MABA method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4028867,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3009438,=,1,1,=,,MIC90,nM,,230.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.23
51872,,,18142177,[],CHEMBL4031543,Antitubercular activity against rifampicin resistant Mycobacterium tuberculosis H37Rv ATCC 35838 after 24 hrs by MABA method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4028867,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3009438,=,1,1,=,,MIC90,nM,,120.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.12
51873,,,18142187,[],CHEMBL4031544,Antitubercular activity against moxifloxacin resistant Mycobacterium tuberculosis H37Rv after 24 hrs by MABA method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4028867,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3009438,>,1,1,>,,MIC90,nM,,8000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,8.0
51874,,,18142197,[],CHEMBL4031545,Antitubercular activity against bedaquiline resistant Mycobacterium tuberculosis H37Rv after 24 hrs by MABA method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4028867,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3009438,=,1,1,=,,MIC90,nM,,260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.26
51875,,,18142207,[],CHEMBL4031546,Antitubercular activity against capreomycin resistant Mycobacterium tuberculosis H37Rv after 24 hrs by MABA method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4028867,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3009438,=,1,1,=,,MIC90,nM,,350.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.35
51876,,,18142217,[],CHEMBL4031547,Antitubercular activity against streptomycin resistant Mycobacterium tuberculosis H37Rv ATCC 35820 after 24 hrs by MABA method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4028867,J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3009438,=,1,1,=,,MIC90,nM,,360.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.36
51877,,,18222699,[],CHEMBL4048061,Antibacterial activity against clinical isolates of Escherichia coli by broth microdilution assay,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4043274,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3023914,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.06
51878,,,18222703,[],CHEMBL4048062,Antibacterial activity against multidrug resistant Staphylococcus aureus by broth microdilution assay,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4043274,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3023914,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
51879,,,18222707,[],CHEMBL4048061,Antibacterial activity against clinical isolates of Escherichia coli by broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4043274,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3023914,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
51880,,,18222711,[],CHEMBL4048062,Antibacterial activity against multidrug resistant Staphylococcus aureus by broth microdilution assay,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4043274,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3023914,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,32.0
51881,,,18222715,[],CHEMBL4048061,Antibacterial activity against clinical isolates of Escherichia coli by broth microdilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4043274,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3023914,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,32.0,0.06
51882,,,18222719,[],CHEMBL4048062,Antibacterial activity against multidrug resistant Staphylococcus aureus by broth microdilution assay,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4043274,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3023914,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,32.0,0.06
51883,,,18222753,[],CHEMBL4048074,Antibacterial activity against wild-type Escherichia coli ATCC 25922 infected in iv dosed CD-1 mouse assessed as mouse survival treated for 1 hr followed by reinfection with bacteria measured at 96 hrs post infection,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4043274,Bioorg Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3023914,<,1,0,<,,PD50,mg kg-1,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,3.0
51884,,,18333518,[],CHEMBL4136664,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 10 days under low oxygen condition followed by second incubation under aerobic condition for 28 hrs by LORA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4130595,ACS Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3044207,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
51885,,,18333527,[],CHEMBL4136663,Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 7 days under aerobic condition by alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4130595,ACS Med Chem Lett,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3044207,=,1,1,=,,MIC,nM,,420.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.42
51886,,Not Determined,18362418,[],CHEMBL4142033,Antibacterial activity against Enterococcus faecalis NCTC 12697 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3047788,,1,0,,,MIC,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,,,,
51887,,Not Determined,18362453,[],CHEMBL4142034,Antibacterial activity against Bacillus subtilis NCTC 10400 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3047788,,1,0,,,MIC,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,,,,
51888,,Not Determined,18362488,[],CHEMBL4142035,Antibacterial activity against methicillin-sensitive Staphylococcus aureus NCTC 12981 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3047788,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
51889,,Not Determined,18362523,[],CHEMBL4142036,Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 13373 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3047788,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
51890,,,18362558,[],CHEMBL4142037,Antibacterial activity against Norfloxacin-resistant Staphylococcus aureus 1199B over-expressing NorA after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3047788,=,1,1,=,,MIC,nM,,620.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.62
51891,,,18362593,[],CHEMBL4142038,Antibacterial activity against erythromycin-resistant Staphylococcus aureus RN4220 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3047788,=,1,1,=,,MIC,nM,,310.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.31
51892,,Not Determined,18362628,[],CHEMBL4142039,Antibacterial activity against Staphylococcus aureus EMRSA-15 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3047788,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
51893,,Not Determined,18362663,[],CHEMBL4142040,Antibacterial activity against tetracycline/methicillin-resistant Staphylococcus aureus XU212 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3047788,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
51894,,,18371819,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL4143615,"AUC (0 to infinity) in ICR mouse at 50 mg/kg, po by HPLC analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3049393,=,1,1,=,,AUC,ng.hr.mL-1,,7032.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ng.hr/ml,,,7032.0
51895,,,18371821,[],CHEMBL4143614,"Tmax in ICR mouse at 50 mg/kg, po by HPLC analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,3049393,=,1,1,=,,Tmax,hr,,1.08,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,hr,UO_0000032,,1.08
51896,,,18371823,[],CHEMBL4143616,"Elimination half life in ICR mouse at 50 mg/kg, po by HPLC analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,3049393,=,1,1,=,,T1/2,hr,,11.35,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,beta t1/2,hr,UO_0000032,,11.35
51897,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,18371825,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4143618,"Cmax in ICR mouse at 50 mg/kg, po by HPLC analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3049393,=,1,1,=,,Cmax,nM,,6803.01,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ng/ml,UO_0000065,,2731.0
51898,,,18371827,[],CHEMBL4143617,Half life in mouse microsomes,A,,,BAO_0002115,BAO_0000251,microsome format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,3049393,>,1,1,>,,T1/2,hr,,1.0,CHEMBL612558,,ADMET,,,,t1/2,min,UO_0000032,,60.0
51899,,,18371831,[],CHEMBL4143622,"Selectivity index, ratio of CC50 against African green monkey Vero cells to MIC for Mycobacterium tuberculosis H37Rv",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3049393,=,1,0,=,,Selectivity Index,,,1280.0,CHEMBL612545,,Unchecked,,,,Selectivity Index,,,,1280.0
51900,,,18371846,[],CHEMBL4143621,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 72 hrs by MTT assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3049393,=,1,1,=,,CC50,ug.mL-1,,128.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,CC50,ug ml-1,UO_0000274,,128.0
51901,,,18371855,[],CHEMBL4143620,Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis after 3 days by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3049393,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.12
51902,,,18371879,[],CHEMBL4143619,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 days by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4138241,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3049393,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.1
51903,,,18451741,[],CHEMBL4178650,Antibacterial activity against Mycobacterium tuberculosis H37Rv nutrient starvation model assessed as log reduction in bacterial colonies at 10 ug/ml measured after 7 days by MPN assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4177555,Bioorg Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3062227,=,1,0,=,,log(activity),,,2.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log(activity),,,,2.2
51904,,,18451746,[],CHEMBL4178651,Antibiofilm activity against Mycobacterium tuberculosis assessed as log reduction in bacterial count at 10 ug/ml measured after 7 days by MPN assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4177555,Bioorg Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3062227,=,1,0,=,,log(activity),,,1.8,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log(activity),,,,1.8
51905,,,18451749,[],CHEMBL4178653,"Antibacterial activity against Mycobacterium marinum ATCC BAA-535 infected in Zebra fish assessed as log reduction in bacterial counts at 10 mg/kg, po administered for 7 days by MPN assay",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4177555,Bioorg Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3062227,=,1,0,=,,log(activity),,,2.7,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,log(activity),,,,2.7
51906,,,18487872,[],CHEMBL4186805,"Antibacterial activity against Mycobacterium marinum ATCC BAA-535 infected in zebra fish assessed as log reduction in bacterial load at 10 mg/kg, po for 7 days",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4184184,Bioorg Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3068683,=,1,0,=,,log(activity),,,2.5,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,log(activity),,,,2.5
51907,,,18487875,[],CHEMBL4186803,Antibiofilm activity against Mycobacterium tuberculosis H37Rv at 10 ug/ml after 1 week,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4184184,Bioorg Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3068683,=,1,0,=,,log(activity),,,1.8,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log(activity),,,,1.8
51908,,Active,18487894,[],CHEMBL4186798,Antibacterial activity against non replicating Mycobacterium tuberculosis H37Rv assessed as log reduction in bacterial count at 10 ug/ml incubated for 7 days followed by compound dilution measured after 4 weeks,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4184184,Bioorg Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3068683,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
51909,,,18530113,[],CHEMBL4195075,Antibacterial activity against wild type Escherichia coli ATCC 25922 by CLSI M100-S17 protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076638,=,1,1,=,,MIC,ug.mL-1,,0.024,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.024
51910,,,18530114,[],CHEMBL4195091,"Terminal half life in CD1 mouse plasma at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,3076638,=,1,1,=,,T1/2,hr,,1.8,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,beta t1/2,hr,UO_0000032,,1.8
51911,,,18530115,[],CHEMBL4195098,"Volume of distribution at steady state in CD1 mouse plasma at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3076638,=,1,1,=,,Vdss,L.kg-1,,3.7,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Vdss,L/Kg,UO_0000197,,3.7
51912,,,18530116,[],CHEMBL4195099,"Clearance in CD1 mouse plasma at 10 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3076638,=,1,1,=,,CL,mL.min-1.kg-1,,72.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CL,ml/min.kg,,,72.0
51913,,Not Determined,18530117,[],CHEMBL4195100,Oral bioavailability in CD1 mouse plasma by LC-MS/MS analysis,A,,,BAO_0003042,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3076638,,1,0,,,F,%,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,F,,UO_0000187,,
51914,,,18530118,[],CHEMBL4195101,Fraction unbound in mouse plasma at 1 uM by equilibrium dialysis method,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3076638,=,1,1,=,,Fu,,,0.8,CHEMBL612558,,ADMET,,,,Fu,,,,0.8
51915,,,18530119,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL4195102,"AUC (0 to 24 hrs) in CD1 mouse plasma at 3 mg/kg, iv by LC-MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3076638,=,1,1,=,,AUC,ng.hr.mL-1,,640.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,hr.microg/ml,,,0.64
51916,,,18530120,[],CHEMBL4195115,"Antibacterial activity against Escherichia coli infected in cyclophosphamide treated neutropenic CD1 mouse septicemia model assessed as mouse survival at 3 mg/kg, iv dosed at 1 hr post infection followed by redosing at 5 hrs post infection measured at 96 hrs post infection relative to control",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3076638,=,1,0,=,,Survival,%,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Survival,%,UO_0000187,,100.0
51917,,,18530121,[],CHEMBL4195117,"Antibacterial activity against Escherichia coli infected in cyclophosphamide treated neutropenic CD1 mouse septicemia model assessed as mouse survival at 1.5 mg/kg, iv dosed at 1 hr post infection followed by redosing at 5 hrs post infection measured at 96 hrs post infection relative to control",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190388,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3076638,=,1,0,=,,Survival,%,,83.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Survival,%,UO_0000187,,83.0
51918,,,18534265,[],CHEMBL4195845,"Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6 mouse assessed as log reduction in bacterial load in lungs at 30 mg/kg, po for 8 consecutive days starting from day 1 post infection measured on day 9 post last dose",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190407,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3077252,=,1,0,=,,log(activity),,,2.8,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log(activity),,,,2.8
51919,,,18534267,[],CHEMBL4195891,"Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6 mouse assessed as bacterial load in lungs at 30 mg/kg, po for 8 consecutive days starting from day 1 post infection measured on day 9 post last dose (Rvb = 6.8 +/- 0.2 No_unit)",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190407,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3077252,=,1,0,=,,Activity,log10CFU,,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU,,,4.0
51920,,Non-Toxic,18534268,[],CHEMBL4195892,"Toxicity in C57BL/6 mouse infected with Mycobacterium tuberculosis H37Rv at 30 mg/kg, po for 8 consecutive days starting from day 1 post infection",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4190407,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3077252,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
51921,,,18581975,[],CHEMBL4222876,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate CCARM 3167 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085802,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51922,,,18582002,[],CHEMBL4222875,Antibacterial activity against quinolone-resistant Staphylococcus aureus isolate CCARM 3505 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085802,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51923,,,18582035,[],CHEMBL4222874,Antibacterial activity against Staphylococcus aureus 4220 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085802,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51924,,,18582052,[],CHEMBL4222877,Antibacterial activity against Streptococcus mutans 3289 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085802,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,ug ml-1,UO_0000274,,0.5
51925,,,18582079,[],CHEMBL4222878,Antifungal activity against Candida albicans 7535 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085802,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,2.0
51926,,,18582106,[],CHEMBL4222879,Antibacterial activity against Escherichia coli 1924 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085802,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
51927,,,18582133,[],CHEMBL4222880,Antibacterial activity against Pseudomonas aeruginosa 2742 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085802,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
51928,,,18653871,[],CHEMBL4230262,Antibacterial activity against multidrug resistant Mycobacterium tuberculosis ATTC 27294 by Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229334,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3098182,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,0.6,0.1
51929,,,18653873,[],CHEMBL4230281,Antitubercular activity against replicating Mycobacterium tuberculosis H37Rv by Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229334,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3098182,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.1
51930,,,18653875,[],CHEMBL4230280,Antitubercular activity against non-replicating Mycobacterium tuberculosis H37Rv after 10 days by low oxygen recovery assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229334,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3098182,=,1,1,=,,MIC,ug.mL-1,,9.19,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,9.19
51931,,,18670112,[],CHEMBL4234503,"Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6J mouse assessed as log10 CFU reduction in bacterial lung count at 30 mg/kg, po administered once daily for 8 days measured post last dose relative to control",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229459,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3100843,=,1,0,=,,FC,,,3.4,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,FC,,,,3.4
51932,,,18673104,[],CHEMBL4235060,Antibacterial activity against Staphylococcus aureus SMITH after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.025
51933,,,18673112,[],CHEMBL4235061,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae J24 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.1
51934,,,18673120,[],CHEMBL4235062,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae J41 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.1
51935,,,18673128,[],CHEMBL4235063,Antibacterial activity against Streptococcus pyogenes ATCC 12344 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.2
51936,,,18673136,[],CHEMBL4235064,Antibacterial activity against Enterococcus faecalis ATCC 19433 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.2
51937,,,18673144,[],CHEMBL4235065,Antibacterial activity against Bacillus subtilis ATCC 6633 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MIC,ug ml-1,UO_0000274,,0.025
51938,,,18673152,[],CHEMBL4235066,Antibacterial activity against Escherichia coli NIHJ after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
51939,,,18673160,[],CHEMBL4235067,Antibacterial activity against Klebsiella pneumoniae TYPE 1 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
51940,,,18673168,[],CHEMBL4235068,Antibacterial activity against Haemophilus influenzae ATCC 49247 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.012
51941,,,18673176,[],CHEMBL4235069,Antibacterial activity against Moraxella catarrhalis ATCC 25238 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.05
51942,,,18673184,[],CHEMBL4235070,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
51943,,,18673192,[],CHEMBL4235071,Antibacterial activity against levofloxacin and methicillin-resistant Staphylococcus aureus 870307 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
51944,,,18673200,[],CHEMBL4235072,Antibacterial activity against levofloxacin and methicillin-resistant Staphylococcus aureus 890325-1 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
51945,,,18673204,[],CHEMBL4235073,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 033806 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
51946,,,18673212,[],CHEMBL4235074,Antibacterial activity against quinolone-resistant Escherichia coli DNS5101 after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,>,1,1,>,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
51947,,,18673220,[],CHEMBL4235075,Antibacterial activity against Escherichia coli 5-037042'98 harboring gyrase A Asp87Gly mutation after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
51948,,,18673224,[],CHEMBL4235076,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,16.0,0.015
51949,,,18673229,[],CHEMBL4235076,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.06
51950,,,18673234,[],CHEMBL4235076,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 hrs by two-fold microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101429,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
51951,,,18673239,[],CHEMBL4235077,Inhibition of human ERG expressed in CHOK1 cells at 30 uM,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://qudt.org/vocab/unit#Percent,3101429,=,1,1,=,,Inhibition,%,,22.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,INH,%,UO_0000187,,22.0
51952,,,18673247,[],CHEMBL4235079,"Apparent partition coefficient, log P of the compound in CHCL3/03.1 M phosphate buffer at pH 7.4",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3101429,=,1,1,=,,LogP,,,54.0,CHEMBL2362975,,No relevant target,,,,logP,,,,54.0
51953,,,18673251,[],CHEMBL4235080,Inhibition of human ERG expressed in CHOK1 cells at 100 uM,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://qudt.org/vocab/unit#Percent,3101429,=,1,1,=,,Inhibition,%,,42.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,INH,%,UO_0000187,,42.0
51954,,,18673258,[],CHEMBL4235082,Metabolic stability in human microsomes at 1 uM assessed as compound remaining after 30 mins,A,,,BAO_0000179,BAO_0000251,microsome format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3101429,=,1,1,=,,Stability,%,,92.0,CHEMBL612558,,ADMET,,,,Stability,%,UO_0000187,,92.0
51955,,,18673263,[],CHEMBL4235083,Binding affinity to human serum albumin after 60 mins at 37 degC by ultrafiltration-based LC-MS analysis,A,,,BAO_0000179,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3101429,=,1,1,=,,PPB,%,,1.3,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,PB,%,UO_0000187,,1.3
51956,,,18673267,[],CHEMBL4235084,Inhibition of CYP3A4 in human liver microsomes at 10 uM assessed as remaining activity by measuring 1'-hydroxylation of midazolam after 30 mins,A,,,BAO_0001103,BAO_0000251,microsome format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3101429,=,1,0,=,,Activity,%,,97.9,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Activity,%,UO_0000187,,97.9
51957,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,18673273,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4235085,"Cmax in Crj:CD rat at 5 mg/kg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3101429,=,1,1,=,,Cmax,nM,,3711.64,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,1.49
51958,,,18673279,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '8.0'}]",CHEMBL4235086,"AUC (0 to 8 hrs) in Crj:CD rat at 5 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3101429,=,1,1,=,,AUC,ng.hr.mL-1,,4460.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,microg.hr/mL,,,4.46
51959,,Active,18673330,[],CHEMBL4235106,"In vivo antibacterial activity against quinolone-sensitive and penicillin-resistant Streptococcus pneumoniae 033806 infected in CBA/JNCrj mouse assessed as reduction in bacterial count at 40 to 80 mg/kg, sc administered twice per day starting from 1 day after infection and measured on day after final dose",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229492,J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3101429,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
51960,,,18679633,[],CHEMBL4236328,Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv harboring RpoB S522L mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229544,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3102467,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.04
51961,,,18679639,[],CHEMBL4236327,Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv harboring katG Y155 mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229544,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3102467,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.04
51962,,,18679645,[],CHEMBL4236326,Antitubercular activity against fluoroquinolone-resistant Mycobacterium tuberculosis H37Rv harboring gyrA D94N mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229544,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3102467,=,1,1,=,,MIC,ug.mL-1,,3.9,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.9
51963,,,18679748,[],CHEMBL4236309,Antibacterial activity against Mycobacterium smegmatis ATCC 19420,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229544,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3102467,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.03
51964,,Not Determined,18679751,[],CHEMBL4236310,Antibacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4229544,Bioorg Med Chem Lett,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3102467,,1,0,,,MIC,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,,,,
51965,,,18699996,[],CHEMBL4254716,Antibiofilm activity against Mycobacterium tuberculosis H37Rv assessed as log reduction in bacterial load at 10 ug/ml incubated for 1 week by MPN assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4251635,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3105575,=,1,0,=,,log(activity),,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log(activity),,,,2.0
51966,,,18699999,[],CHEMBL4254718,"Antimycobacterial activity against Mycobacterium marinum ATCC BAA-535 infected in zebrafish at 5 mg/kg, po treated for 7 days by MPN assay",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4251635,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3105575,=,1,0,=,,log(activity),,,2.4,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,log(activity),,,,2.4
51967,,,18700031,[],CHEMBL4254720,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv dormant stage assessed as log reduction in bacterial load at 10 ug/ml incubated for 7 days,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4251635,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3105575,=,1,0,=,,log(activity),,,0.3,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log(activity),,,,0.3
51968,,,18702095,[],CHEMBL4255062,"Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6 mouse assessed as change in bacterial burden in lungs at 30 mg/kg, po once daily for 8 days",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4251653,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3105977,=,1,0,=,,Activity,log10CFU,,3.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU,,,3.1
51969,,,18743345,[],CHEMBL4262670,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 measured after 7 days by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4261527,Medchemcomm,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3114157,=,1,1,=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
51970,,,18828943,[],CHEMBL4303819,Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4303097,,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3135485,=,52,0,=,,Inhibition index,,,0.8056,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition index,,,,0.805570448
51971,,,18836348,[],CHEMBL4303810,Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits),F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4303122,,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3142618,=,52,0,=,,Hit score,,,0.09676,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Hit score,,,,0.096761429
51972,,,18860514,[],CHEMBL4308583,Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6 mouse assessed as reduction in bacterial load in lungs at 30 mg/kg administered once daily starting from 5 days post infection for 4 consecutive days and measured on day 9,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4304832,ACS Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3148269,=,1,0,=,,Activity,log10CFU,,3.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU,,,3.5
51973,,,18875672,[],CHEMBL4310739,Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149804,=,1,1,=,,MIC,ug.mL-1,,0.42,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.42
51974,,,18875677,[],CHEMBL4310740,Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149804,=,1,1,=,,MIC,ug.mL-1,,0.49,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.49
51975,,,18875682,[],CHEMBL4310741,Antitubercular activity against streptomycin-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149804,=,1,1,=,,MIC,ug.mL-1,,0.94,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.94
51976,,,18875687,[],CHEMBL4310743,Antitubercular activity against kanamycin-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149804,=,1,1,=,,MIC,ug.mL-1,,0.21,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.21
51977,,,18875692,[],CHEMBL4310744,Antitubercular activity against moxifloxacin-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149804,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,16.0
51978,,,18875697,[],CHEMBL4310745,Antitubercular activity against d-cycloserine-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149804,=,1,1,=,,MIC,ug.mL-1,,0.46,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.46
51979,,,18911546,[],CHEMBL4321113,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154621,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51980,,,18911578,[],CHEMBL4321114,Antibacterial activity against Streptococcus mutans 3289 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154621,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,ug ml-1,UO_0000274,,0.25
51981,,,18911610,[],CHEMBL4321115,Antibacterial activity against Escherichia coli KCTC 1924 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154621,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51982,,Not Determined,18911642,[],CHEMBL4321116,Antifungal activity against Candida albicans 7535 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3154621,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
51983,,,18911674,[],CHEMBL4321117,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154621,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51984,,,18911706,[],CHEMBL4321118,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154621,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51985,,,18911738,[],CHEMBL4321119,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154621,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51986,,,18911770,[],CHEMBL4321120,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154621,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51987,,,19004456,[],CHEMBL4344029,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as log reduction in bacterial population at 10 ug/ml under starvation condition after 7 days by MPN assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4342442,J Nat Prod,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3171201,=,1,0,=,,FC,,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,FC,,,,2.0
51988,,,19027501,[],CHEMBL4348794,Antibacterial activity against Staphylococcus aureus RN4220 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
51989,,,19027530,[],CHEMBL4348795,Antibacterial activity against Staphylococcus aureus KCTC209 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51990,,,19027559,[],CHEMBL4348796,Antibacterial activity against Staphylococcus aureus KCTC503 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
51991,,,19027588,[],CHEMBL4348797,Antibacterial activity against Streptococcus mutans KCTC3289 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,ug ml-1,UO_0000274,,0.25
51992,,,19027617,[],CHEMBL4348798,Antibacterial activity against Escherichia coli 1924 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
51993,,,19027646,[],CHEMBL4348799,Antibacterial activity against Pseudomonas aeruginosa 2742 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
51994,,,19027675,[],CHEMBL4348800,Antifungal activity against Candida albicans 7535 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,0.5
51995,,,19027704,[],CHEMBL4348801,Antibacterial activity against Methicillin-resistant Staphylococcus aureus CCARM 3167 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51996,,,19027734,[],CHEMBL4348802,Antibacterial activity against Methicillin-resistant Staphylococcus aureus CCARM 3506 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
51997,,,19027764,[],CHEMBL4348803,Antibacterial activity against Quinolone-resistant Staphylococcus aureus CCARM 3505 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51998,,,19027794,[],CHEMBL4348804,Antibacterial activity against Quinolone-resistant Staphylococcus aureus CCARM 3519 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174486,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
51999,,,19051582,[],CHEMBL4354972,Antibacterial activity against Pseudomonas aeruginosa by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,mg/L,UO_0000274,,8.0
